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ABSTRACT 
 
   AEC syndrome is a rare autosomal dominant disorder, characterized by skin 
erosions, ectodermal dysplasia and cleft lip and/or palate. Missense mutations 
in the p63 gene, a key regulator of stratified epithelia, are causative of the 
disorder. The pathogenesis and the biological mechanisms underlying the skin 
erosions of AEC syndrome have been elusive. We generated a conditional 
knock-in mouse model carrying an inducible L514F mutation, found in AEC 
patients. p63+/floxL514F mice were crossed with the K14-Cre knock-in mouse line 
to obtain p63L514F expression soon before birth. Newborn mutant mice were 
indistinguishable from their wild-type littermates, however few days after birth 
focal skin blistering and scaling was observed accompanied by weight loss and 
often by death. Histological analysis and dye penetration assays revealed focal 
disruption of the epidermal barrier, followed by severe skin inflammation and 
epidermal hyperplasia. Consistently with the focal gaps in the epidermis of 
mutant mice, we found a strong reduction of desmosomal component Dsg1, 
Dsc3 and Dsp and a downregulation of two components of adherens junctions, 
Pvrl1 and Pvrl4 in AEC mutant keratinocytes. Similar results were obtained in 
human keratinocytes derived from AEC patients, indicating impaired cell-cell 
adhesion is AEC syndrome. In addition, we found an unbalance in the basal 
keratins. The intermediate filaments keratin5 (Krt5) and keratin14 (Krt14) are 
essential to withstand mechanical stress in the epidermis and are known p63 
target genes. Both Krt5 and Krt14 expression was strongly downregulated in 
AEC mutant keratinocytes and in p63 knockdown, whereas in AEC mutant 
epidermis only Krt5 was significantly affected indicating that in vivo p63 plays 
a crucial function in Krt5 regulation. Importantly, we found a strong reduction 
in KRT5 expression also in human AEC patients, thus indicating impaired 
intermediate filaments network in AEC syndrome. Consistent with a reduction 
in Krt5, a reduced number of keratin bundles were observed by tissue-electron 
microscopy  (TEM) in the basal compartment of the epidermis.  
Skin fragility lead to focal failure of epidermal barrier, causing a progressive 
inflammation characterized by hyperplasia and hyperkeratosis in the skin of 
mutant mice. Clear signs of severe inflammation were preceded by strongly 
elevated levels of Thymic stromal lymphopoietin (Tslp), an IL-7 like cytokine, 
known to cause systemic defects which were observed in AEC mice and in at 
least one AEC patient. Strong induction of Tslp was associated with reduced 
Notch expression. Interestingly, reactivation of the Notch pathway could 
reduce Tslp expression in mutant keratinocytes. 
Together these data support the hypothesis that the basal cell fragility and 
blistering observed in p63 mutant mice and AEC patients are due to alteration 
in adhesion molecules belonging to different categories. These results together 
with reduced Notch signaling lead to excessive production of the 
proinflammatory molecule Tslp. 
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1. BACKGROUND 
 
 
1.1 The epidermis 
 
   The epidermis is the uppermost, multilayered compartment of the skin that 
serves as a protective barrier against external environmental insults, 
mechanical trauma and dehydration. The skin epidermis rests on the basement 
membrane rich in extracellular matrix, which separates the epidermis and its 
appendages from the underlying dermis. It is composed of 4-5 layers 
depending on the region of skin being considered. Those layers in descending 
order are the cornified layer (stratum corneum), granular layer, spinous layer 
and basal layer (Fig. 1). The stratified squamous epithelium of the epidermis is 
maintained by cell division within the basal layer.  During the epidermal 
maturation the cells undergo a complex series of morphological and 
biochemical changes that result in the production of the stratum corneum, the 
highly cornified outermost layer of the tissue composed by cornified cell 
envelopes assembled by cross-linking of structural proteins and lipids.  More in 
detail, the cells of the basal layer remain attached to an underlying matrix 
through a series of adhesion molecules such as hemidesmosome, laminin and 
anchoring fibrils, and proliferate. Some of their daughter keratinocytes enter 
the spinous layer through asymmetric mitoses, where they exit the cell cycle, 
grow larger and establish robust intercellular connections (Simpson et al., 
2011). The cells switch expression of basal layer specific keratins, Keratin5 
and Keratin 14, to Keratin1 and Keratin10 (Krt1; Krt10) typical of the spinous 
layer (Fuchs and Green, 1980). In addition other keratins are also expressed 
suprabasally, as Keratin6, Keratin16 and Krt17 (Krt6; Krt16 and Krt17), but 
only in hyperproliferative condition such as wound healing. The spinous layer 
also contains Langerhans cells, which are derived from a precursor in bone 
marrow and are involved in immune response. Above the spinous layer, 
keratinocytes contain numerous electrondense keratohyalin granules packed 
with the protein profilaggrin in their cytoplasm, hence the name “stratum 
granulosum”. Cells in the granular layer flatten and assemble a water-
impermeable cornified envelope underlying the plasma membrane and express 
filaggrin (Flg) and loricrin (Lor) as markers. In addition, cornified envelope 
proteins, which are rich in glutamine and lysine residues, are synthesized and 
deposited under the plasma membrane of the granular cells. As response to the 
increased permeability to the calcium, the cells activate transglutaminase, 
generating  -glutamyl  -lysine crosslinks to create an indestructible barrier. 
Finally, stratum corneum keratinocytes release lysosomal enzymes to degrade 
major organelles, including the nucleus. The final steps of terminal 
differentiation involve also the extrusion of lipid bilayers, packaged in lamellar 
granules, onto the scaffold of the cornified envelope. The dead stratum 
corneum cells create an impenetrable layer that is continually replaced (Fuchs, 
2007). 
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   Keratinocytes move from the proliferative basal layer through the granular 
layer and continually replaced the cells of the outward layers. Indeed, as the 
body’s outer frontier, the epidermis is subject to repeated trauma that must be 
repaired after wounding. (Shen et al., 2013). Within this layer, epidermal stem 
cells divide to self-renew and produce transient amplifying (TA) cells, which 
possess a more limited proliferative capacity. Transit amplifying cells 
constitute the major cell type in the basal layer of the developing and mature 
epidermis and after few rounds of cell division they exit from the cell cycle, 
and initiate a terminal differentiation program, as they migrate outward toward 
the tissue surface.  
 
  
Figure 1. Epidermal architecture. The epidermis is a stratified epithelia 
composed by the indicated layers and is separated from the dermis by the 
basement membrane that is functionally organized in the lamina lucida (gray) 
and the lamina densa (pink). Each layer of the epidermis is characterized by 
specific cell–matrix and cell– cell adhesion molecules. Here, we represent 
adherens junction (green), desmosome (violet) and tight junction (blue) that are 
required for cell–cell contacts and hemidesmosomes (red) that connect basal 
cells to the basement membrane. Anchoring filaments (blue) span the basement 
membrane contacting anchoring fibrils (red) that connect the lamina densa to 
the anchoring plaques within the dermis (not represented). p63 direct target 
genes involved in cell adhesion and the localization of their protein products 
are shown (from Ferone et al., 2015). 
 
1.2 Structure and function of p63 
 
   p63 is a tetrameric transcription factor belonging to the p53 gene family 
consisting of three genes, p53, p63, and p73 (Yang et al., 2002). They share 
three functional domains: an N-terminal transactivation domain which shares 
25% homology with N-terminal part of p53, a central DNA binding domain 
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which shares 65% of homology with the corresponding p53 domain and C-
terminal tetramerization domain, which shares 35% of homology with the 
oligomerization domain of p53 (Yang et al., 2002). p63, p53 and the third 
member p73, constitute a family of key transcriptional regulators in cell 
growth, differentiation and apoptosis. Indeed, while p53 is a major player in 
tumorigenesis (Kemp et al., 1994), p63 and p73 encompass pivotal roles in 
embryonic development (Mills et al., 1999; Yang et al., 2000). More in detail, 
p63 has a crucial role in embryonic development of stratified epithelia where it 
can function either as an activator or a repressor (Koster and Roop, 2004; 
LeBoeuf et al., 2010). In particular, p63 is a master regulator of epidermal gene 
expression and it is critical for cell proliferation (Truong et al., 2006; Senoo et 
al., 2007; Antonini et al., 2010), cell adhesion (Carroll et al., 2006; Koster et 
al., 2007) and stratification (Koster and Roop, 2004; Truong et al., 2006) while 
suppressing terminal differentiation (Nguyen et al., 2006).  
   p63 consists of 16 exons located on chromosome 3q28. It has two 
independent transcriptional start sites that give rise to two different N-termini 
isoforms: TA and  N that in turn produce      or   ends as the result of 
alternative splicing events towards the C-terminal region, therefore at least six 
different protein isoforms can be produced (Yang et al., 1998). In particular, 
TAp63 contains an acidic N-terminal transactivation domain similar to the one 
found in the canonical full-length p53. TAp63 is expressed at very low levels 
in most tissues, whereas it is constitutively expressed in female germ cells 
where it is activated by phosphorylation upon DNA damage, inducing oocyte 
death (Suh et al., 2006; Gonfloni et al., 2009; Kerr et al., 2012). In contrast 
∆Np63 is abundant in the basal regenerative layer of the epidermis and other 
stratified epithelia, and it is virtually absent in other tissues (Yang et al., 1998). 
∆Np63 is by far the most abundant protein in keratinocytes and in the 
epidermis whereas the TAp63 is barely detectable by RNA-seq (Rizzo et al., 
2014). The first 26 amino acids of the N-terminal region in ∆Np63 are required 
for its transcriptional activity, together with the proline-rich domain (PR) and a 
domain (TA2) located between the OD and the SAM (sterile-α-motif) domain 
(Dohn et al., 2001; Ghioni et al., 2002; Helton et al., 2006). The main isoform 
expressed in stratified epithelia is the p63α that contains at the C-terminal end 
a SAM domain and a post-SAM domain (PS) absent in p63ß, p63γ, or in p53 
(Yang et al., 1998). SAM domains have diverse functions and can interact with 
themselves, bind to other SAM domains, bind to non–SAM domain proteins, 
or to RNA (Qiao and Bowie, 2005). The SAM domain in p63 is a five helical 
bundle domain, is unable to form homodimers (Chi et al., 1999; McGrath et al., 
2001) and its function remains uncovered. The PS domain is also called 
transcriptional inhibitory domain (TID) and it is composed of two elements. 
The first interacts with the TA domain of another TAp63 molecule, forming a 
closed and inactive dimer that can be activated by phosphorylation, resulting in 
an active tetramer (Su et al., 2010; Deutsch et al., 2011). The other element 
controls p63 protein concentration via a sumoylation-dependent mechanism 
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(Straub et al., 2010). However, the functional role of the PS domain in the 
context of the ∆Np63α that lacks the TA domain is poorly understood. 
 
 
  
Figure 2. p63 gene and protein structure. a) p63 gene structure showing the 
two transcription start sites (P1 and P2) which give rise to TAp63 and ∆Np63 
transcripts, and the splicing variants at the 3’ end, which lead to the      
and   isoforms. In the lower panel, the TAp63  and ∆Np63          
isoforms are represented. Conserved protein domains are: Transactivation 
domain (TA); proline rich domain (PR); DNA-binding domain (DBD); 
Oligomerization domain (OD); SAM (Sterile Alpha Motif) domain; post-SAM 
domain (PS) (from Ferone et al., 2015). 
 
1.3 Phenotype of p63 deficient mice  
 
   The generation of p63-deficient mouse models by two independent groups 
shed light on the crucial role of p63 in the development of ectodermal derived 
tissues. Indeed, mice lacking the p63 gene die for dehydration soon after birth 
and display severe defects of all stratified epithelia and their derivatives, facial 
clefting and impaired limb formation, suggesting that p63 plays a non-
redundant role in these tissues (Mills et al., 1999; Yang et al., 1999).  Defects 
in the surface epithelium of p63-null mice have been ascribed to loss of 
proliferative potential of keratinocyte stem cells (Yang et al., 1999; Senoo et 
al., 2007), and/or altered epidermal stratification and cell differentiation 
associated with reduced expression levels of Krt5/Krt14 and Krt1/Krt10 (Mills 
et al., 1999; Koster and Roop, 2004; Romano et al., 2009).  
   The knockout mouse models are born alive but have striking developmental 
defects. Their limbs are absent or truncated and also structures dependent upon 
epidermal mesenchymal interactions during embryonic development, such as 
hair follicles, teeth and mammary glands, are absent. Phalanges and carpals 
were absent in both the p63-homozygous mutant, whereas more proximal 
forelimb structures were slightly heterogeneous in the extent of the truncation 
in the two models. The femur and all distal skeletal elements were also absent. 
These defects are caused by a failure of the apical ectodermal ridge (AER) to 
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differentiate. The lack of a proper AER limb buds in p63 null mice results from 
a failure of the ectoderm to undergo growth and differentiation that give rise to 
this stratified epithelium. Indeed, several genes that are important in limb-bud 
outgrowth are not expressed, such as Fgfr8 (a marker of the AER) and Msx-1 
(which expression in the mesenchyme depends on an ectodermal signal), or 
abnormally expressed, such as Lmx-1 (a marker of the dorsal limb 
mesenchyme) (Mills et al., 1999; Yang et al., 1999). 
   The skin in the knockout mouse model generated by McKeon’s group lacks 
expression of the basal layer markers as Krt5 and Krt14 and also spinous layer 
markers Krt1 and Krt10. Neverthless, isolated patch of the epidermis showed 
the expression of late differentiation markers such as Loricrin, Involucrin, 
Filaggrin. The authors argue that p63 is required for the initial development 
and continued regeneration of the epidermis and that the loss of p63 in the 
tissues failed to maintain the proliferative potential of stem cells in skin (Fig. 
3)(Yang et al., 1999). In addition, to reinforce this hypothesis the same authors 
in another study strongly showed that p63 is dispensable to maintain the 
proliferative potential of epithelia stem cells of the thymus and epidermis 
(Senoo et al., 2007). 
 
 
  
 
Figure 3. Phenotype of p63 knockout mice. A) The newborn p63 null mice 
show defects in limb formation and craniofacial defects associated with skin 
and appendages aberrant development for lack of stratification and 
differentiation. B) H&E staining of the epidermis at E17 display p63-/- mice 
lacking squamous stratification in the epidermis. Middle, wilde-type H&E 
control mice showing extensive stratification. In the right the basal staining 
with anti-p63 antibody to show the endogenus expression of p63 in the 
epidermis (adapted from Yang et al., 1999). 
 
   The knockout mice generated by Allan Bradley developped aberrant skin and 
appendages due to lack of stratification and differentiation (Fig. 4)(Mills et al., 
1999). The authors showed that in p63 null mice all structures that required the 
ectodermal mesenchymal signal were compromised because the ectoderm 
failed to receive the signal. They showed that the skin of p63 null mice were 
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covered by a single disorganized layers of ectodermal cells or flattened 
epidermal cells in which they did not detect the expression of any early or late 
differentiation markers. Their results suggested that p63 is the determining 
factor of stratification, and supported the hypothesis that p63 is required for 
simple epithelial cells to commit to a stratified epithelial lineage during 
development (Mills et al., 1999). 
 
 
  
 
Figure 4: The phenotype of p63-deficent newborn mice. A) The p63 null 
mice show severe limb and skin defects. B) The expression of different 
markers in the epidermis of p63 null mice show the staining for Krt14 in red 
and Krt1 and Filaggrin (Fil) in green. Krt14 is weakly express in p63 null mice, 
whereas Krt1 and Fil are not detectable in the epidermis (adapted from Mills et 
al., 1999). 
 
1.4 p63-associated syndromes 
 
   p63 plays an essential role in the regulation of ectodermal, orofacial and limb 
development. In particular, ΔNp63α is thought to play multiple essential roles 
in epidermal development and stratification, keratinocyte proliferation and 
differentiation, controlling expression of several epidermal genes including 
itself and other transcription factors (Yang et al., 1998; Antonini et al., 2006; 
Laurikkala et al., 2006; Nguyen et al., 2006; Truong et al., 2006; Koster et al., 
2007; Moretti et al., 2010; Thomason et al., 2010; Romano et al., 2012). Not 
surprisingly, mice lacking the p63 gene die soon after birth with severe defects 
of skin and all stratified epithelia and their derivatives, craniofacial 
abnormalities and impaired limb formation (Mills et al., 1999; Yang et al., 
1999). Consistently, heterozygous mutations in the human p63 gene are 
responsible for several ectodermal dysplasia (ED) syndromes, which are 
congenital disorders characterized by abnormalities of two or more ectodermal 
structures, such as hair, nails, sweat glands and digits.  In particular, mutations 
in the p63 gene can cause at least five different syndromes: Ectrodactyly, 
Ectodermal defects-Cleft lip/palate syndrome (EEC, OMIM 604292), 
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Ankyloblepharon-Ectodermal defects-Cleft lip/palate syndrome (AEC, OMIM 
106260), Limb Mammary Syndrome (LMS, OMIM 603543), Acro-Dermato-
Ungual-Lacrimal-Tooth syndrome (ADULT, OMIM 103285) and Rapp-
Hodgkin Syndrome (RHS, OMIM 129400). Furthermore, two non-syndromic 
human disorders are caused by p63 mutations: isolated split hand/foot 
malformation (SHFM4, OMIM 605289) and recently non-syndromic cleft lip 
(Brunner et al., 2002; Rinne et al., 2009) (Fig. 5).  
   EEC syndrome is the most common p63-linked ED and is mainly caused by 
point mutation in the DNA binding domain (DBD) of the p63 gene and most 
likely alter the DNA-binding properties of the protein. EEC syndrome 
comprises limb malformation, ectodermal dysplasia (abnormal teeth, skin, hair, 
nails and sweat glands) and orofacial clefting (Rinne et al., 2007). 
Representative limb malformations are ectrodactyly and syndactyly. 
Ectodermal dysplasia is seen as lightly colored, sparse hair and absence of 
eyelashes, eyebrows and alopecia can be observed. Skin is thin and dry, 
sometimes resembling dermatitis. 
   LMS was the first p63 syndrome linked to chromosome region 3q27. 
Mutations in LMS are located in the N- and C-terminus of the p63 gene. The 
LMS phenotype comprises malformations of the hands and/or feet and 
hypoplastic nipples and/or mammary glands. Ectodermal defects are much less 
prominent than in EEC syndrome but mammary gland hypoplasia or aplasia is 
more frequent in LMS than in EEC.  Lacrimal duct obstruction and dystrophic 
nails are frequently observed (59 and 46% respectively), hypohydrosis and 
teeth defects are detected in about 30%, but other ectodermal defects such as 
hair and skin defects are rarely detected if at all. About 70% of LMS patients 
have similar limb malformations as in EEC syndrome, and about 30% orofacial 
clefting, notably always in form of cleft palate(van Bokhoven and Brunner, 
2002). 
   ADULT syndrome phenotype is most similar to LMS syndrome, although 
clear differences can be seen when observing larger families or patient 
population. The main difference with the other p63-associated syndromes is the 
absence of orofacial clefting and the presence of hair and skin defects.  
Neverthless, teeth, skin, nail, hair and lacrimal duct defects are constantly 
present in ADULT syndrome (100, 91, 100%, 53% and 67%, respectively). A 
point mutation in exon 8, changing R298 in the DNA binding domain into 
either a glutamine or a glycine has been found. While EEC syndrome 
mutations in the DNA binding domain impair the binding of p63 protein to 
DNA (Celli et al., 1999), arginine 298 is not located close to the DNA-binding 
interface, and mutation of this arginine does not affect DNA binding (Duijf et 
al., 2002). Two other mutations are located in the N-terminus.  
   RHS share most features with AEC, but is differentially classified because of 
the lack of skin erosions and the absence of ankyloblepharon in Rapp-Hodgkin 
syndrome.  Other ED symptoms, such as orofacial clefting and the absence of 
limb malformations are similar to AEC. In both syndromes clefting in lip 
and/or palate is equally frequent. The strong overlap between AEC and RHS 
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suggest that they are variable manifestations of the same clinical entity (Bertola 
et al., 2004; Rinne et al., 2007). AEC and RHS mutations are located in the C-
terminus of the p63 protein. They are either point mutations in the SAM 
domain or deletions in the SAM or PS domains (Celli et al., 1999; McGrath et 
al., 2001; Barrow et al., 2002; van Bokhoven and Brunner, 2002; Kantaputra et 
al., 2003). 
   SHFM is a pure limb malformation (ectrodactyly and syndactyly) condition, 
without orofacial clefting or ectodermal dysplasia. The non-syndromic SHFM4 
is caused by several mutations, which are dispersed throughout the p63 gene 
Possibly, SHFM is caused by altered protein degradation, even though 
different degradation routes are involved (Rinne et al., 2007). A non-syndromic 
orofacial clefting type was also linked to p63 gene, R313G is the first mutation 
discovered (Leoyklang et al., 2006). 
 
 
  
Figure 5. p63 and its mutations. Spectrum of p63 mutations causative of 
AEC syndrome. Most AEC mutations cluster preferentially in the SAM 
domain and PS domain; however some missense mutations were also identified 
at the 5’ of the ∆Np63 isoform leading to premature termination codons, 
translation re-initiation, and truncation of a non-canonical transactivation 
domain in the DN-specific isoforms (from Ferone et al., 2015). 
 
1.5 AEC syndrome 
 
   Ankyloblepharon-Ectodermal defects Cleft lip/palate syndrome (AEC), also 
known as Hay–Wells syndrome, was first reported by Hay and Wells in 
1976(Hay and Wells, 1976). AEC syndrome is a rare autosomal dominant 
disorder, characterized by congenital fusion of the eyelids (ankyloblepharon), 
ectodermal dysplasia with severe involvement of the skin, and cleft palate with 
or without cleft lip. Clinical manifestations have different penetrance: about 
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75% of patients have severe skin erosions at birth, with some AEC patients 
reported to have up to 70% denuded skin. By 4 – 5 years age erosions could 
disappear, except for the head and auricular region. Clefting occurs 
approximately in 80% of AEC patients. The ankyloblepharon occurs only in 
44% of AEC cases (Fig. 6). Hearing loss has been reported in about 40% of the 
patients. AEC patients have nails and teeth defects in about 75–80% of cases 
(Fig. 6). About half of the patients have lacrimal duct atresia. Dermatological 
features include thin and dry skin, often associated with congenital 
erythroderma, widespread skin erosions at or soon after birth, and erosive 
keratoderma of palms, soles and thin hair and/or alopecia. The most severe 
cutaneous manifestation of this disorder is the skin fragility associated with 
severe skin erosions after birth. Erosions typically involve the scalp, head and 
neck, skin folds, palms, and/or soles and are often accompanied by crusting 
and secondary infection (Fig. 6). Skin lesions are a distinctive signs of AEC 
syndrome. Adult patients can be affected by palmoplantar hyperkeratosis and 
erosive palmoplantar keratoderma with bleeding after extensive walking. The 
biological mechanisms underlying the skin erosions remain unveiled, and 
treatment is limited to gentle wound care and antibiotic treatment to prevent or 
cure infections. Healing is slow and recurrent breakdown is typical.  
   In AEC syndrome pathogenic mutations mainly fall in the C-terminus of p63 
protein and include twenty-five missense and only two frameshift mutations in 
the SAM domain, whereas in the PS domain predominate the frameshift 
mutations that extend p63 protein (Rinne et al., 2009). These mutations give 
rise to mutant p63α proteins with dominant effects towards their wild-type 
counterparts. Recently, novel AEC causative mutations have been identified 
that result in translation re-initiation downstream of the non-canonical 
transactivation domain in the ΔN-specific isoforms, leading to expression of 
truncated ΔNp63 protein with dominant negative effects (Rinne et al., 2008).  
   AEC syndrome differs from the other conditions by the severity of the skin 
phenotype, the occurrence of ankyloblepharon, and the absence or mild limb 
malformations. 
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Figure 6. Clinical presentation of AEC infants. a) A close up of reticulated 
scarring that is typically seen in AEC patients as the results of skin erosions 
healing processes. b) Scalp erosions with hemorrhagic crusting, granulation 
tissue and secondary infection. c) Dystrophic fingernails of AEC patients, 
characterized by small nails with partial loss/absence and distal fraying of the 
nail plate. d) Focal fusion of the eyelids (ankyloblepharon) (Adapted from 
Ferone et al., 2015). 
 
1.6 AEC mouse models 
 
   To study the functional activity of mutant p63 in AEC syndrome a first 
knock-in mouse model (p63+/L514F) was generated in our laboratory (Ferone et 
al., 2012).  
This model carries a phenylalanine substitution in position 514 (L514F) and 
closely resembles the human disease (Ferone et al., 2012). This mutation falls 
in the first helix of the SAM domain and disrupts the folding of the protein. 
Among the AEC causative mutations we decided to focus our attention on 
L514 amino acids for three reasons: first of all, this amino acid is mutated in 
three different amino acids (phenylalanine, valine or serine); this mutation 
affects an amino acid that is predicted to be buried inside the protein and has a 
small solvent accessible surface, so any mutation in this region is likely to 
affect the overall structure and stability of the protein by altering the packing of 
the helices, and moreover the substitution of a leucine with a phenylalanine 
probably cause a severe steric clash between two phenylalanine rings that are 
located close to each other (McGrath et al., 2001; Rinne et al., 2007).  
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   p63+/L514F mouse model is characterized by hypoplastic and fragile skin, 
ectodermal dysplasia and cleft palate (Fig. 7). Ferone et al., 2010, found that 
epidermal hypoplasia and cleft palate are associated with a transient reduction 
in epithelial cell proliferation during development. These defects closely 
resemble those observed in the Fgfr2b-/- mice (De Moerlooze et al., 2000; van 
Bokhoven et al., 2001; Petiot et al., 2003; Rice et al., 2004; Candi et al., 2006). 
Since p63 transcriptionally controls the Fibroblast growth factor receptors 
Fgfr2 and Fgfr3 and their expression, they found that impaired FGF signaling 
downstream of p63 is likely an important determinant of reduced ectodermal 
cell proliferation and defective self-renewing compartment in AEC syndrome. 
Unfortunately, a neonatal lethality due to cleft palate prevented the generation 
of a mouse line and the studying of the adult phenotype.  
 
  
Figure 7. Constitutive AEC mouse model. Comparison between AEC 
syndrome phenotype and constitutive AEC mouse model indicated that the 
mouse model faithfully recapitulated some human features, as cleft palate, skin 
erosions and dental abnormalities. 
 
1.6 p63 and adhesion molecules 
 
   In the epidermis cell adhesion has a fundamental role in supporting epithelia 
formation, structure and maintenance thus enabling skin to support mechanical 
stress and to be impermeable. Three different types of junction complexes 
mediate cell-cell adhesion in epithelia: tight junction, adherens junction and 
desmosomes junction. While the tight junction perform a role in establishment 
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of barrier formation and in para-cellular transport, the adherens junction and 
desmosome are crucial in promoting cell adhesion. 
   Several studies indicate that p63 is a crucial transcriptional regulator of genes 
involved in cell-matrix adhesion and cell-cell adhesion genes, directly 
regulating a subset of extracellular matrix, hemidesmosomal, desmosomal, 
adherens junction and tight junction components (reviewed in (Ferone et al., 
2015)). The importance of these junctions for epidermal integrity is highlighted 
by autoimmune or genetic blistering diseases in humans caused by 
dysfunctional desmosome components (McMillan and Shimizu, 2001). 
   Cell-matrix adhesion molecules allow the anchorage of keratinocytes to the 
basement membrane. In skin as well as in other complex epithelia, multiprotein 
complexes called hemidesmosomes hold this role. Hemidesmosomes consist 
mostly of three single-span transmembrane proteins: (1) heterodimers of 
integrin α6β4 (ITGA6 and ITGB4) that contact laminin filaments; (2) the 
bullous pemphigoid antigen BP180 (COL17A1, or BPAG2) with a long C-
terminal collagenous domain that projects into the extracellular matrix below 
the complex; (3) the tetraspanin CD151 that associates laterally with integrin 
α6β4 (Simpson et al., 2011; Yang et al., 2012). 
   p63 was found to regulate the expression of several integrin subunits, 
including integrin alpha 3, 4, 5 and 6 (Kurata et al., 2004; Carroll et al., 2006; 
Truong et al., 2006) and of the hemidesmosome protein dystonin (Osada et al., 
2005).  
   In addition, p63 is required for expression of some extracellular matrix 
components such as laminin2 (Carroll et al., 2006) and FRAS1 (Koster et al., 
2007), an epidermal ECM protein that, when defective, results in severe 
blistering (McGregor et al., 2003). Direct regulation of Fras1 gene was 
demonstrated in vivo and in vitro (Koster et al., 2007). 
Importantly, global gene expression profiling performed in different cell types 
or tissues indicate that p63 is crucial for expression of integrins and other 
hemidesmosome genes, as well as basement membrane components (Carroll et 
al., 2006; Vigano et al., 2006; Yang et al., 2006; Della Gatta et al., 2008; 
Shalom-Feuerstein et al., 2011).  
   Desmosomes are specialized intercellular complexes, which confer stability 
to tissues by anchoring the plasma membrane of two adjacent cells to their IF 
cytoskeleton (reviewed in (Michels et al., 2009; Simpson et al., 2011). The 
main components of desmosomes belong to three protein families: cadherins, 
armadillo proteins and plakins. Desmogleins (DSG1-4) and desmocollins 
(DSC1-3), members of the cadherin superfamily, are transmembrane proteins, 
which form heterophilic and homophilic interactions in the extracellular space 
between adjacent cells. Their cytoplasmic domain is anchored to the IF 
cytoskeleton via a series of protein– protein interactions involving members of 
the armadillo family such as plakoglobin (JUP) and plakophilins (PKP1- 
PKP3), which in turn bind desmoplakin (DSP), a plakin family member, which 
associates directly to IF (Getsios et al., 2004). Additional desmosomal 
components are required for specialized functions in the epidermis in a cell-
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type-specific manner,for example envoplakin, periplakin and corneodesmosin 
together with DSG1 are essential for corneodesmosomes formation in the 
stratum corneum of the epidermis (Ruhrberg et al., 1996; Ruhrberg et al., 1997; 
Jonca et al., 2002). In addition to these canonical desmosome proteins, a small 
transmembrane polypeptide PERP is an integral component of desmosomes 
and is required for their function (Ihrie et al., 2005).  
   p63 was found to directly regulate the expression of the desmosomal 
component Perp (Ihrie et al., 2005). In the absence of Perp expression, mice 
display severe intra-epidermal blistering underscoring the importance of Perp 
in cell adhesion.  
   In the knock-in mouse model for AEC syndrome (Ferone et al., 2012), 
epidermal blisters are observed primarily between the basal and suprabasal 
layers and are associated to a significant reduction in desmosome contacts 
compared to other type of adhesion molecules. Accordingly, a strong reduction 
in Dsp, Dsc3 and Dsg1 is observed in AEC newborn skin, in isolated AEC 
primary keratinocytes and in human keratinocytes derived from AEC (Ferone 
et al., 2013; Koster et al., 2014). In addition, Dsp, Dsc3, and Dsg1 are also 
downregulated in p63-depleted keratinocytes, and are shown to be direct p63 
target genes (Ferone et al., 2013; Johnson et al., 2014).  
   Adherens junctions (AJ) are intercellular structures that connect actin 
cytoskeleton between neighboring cells (reviewed in (Brandner J.M., 2010). 
They consist of two basic adhesive units: the classical calcium-dependent 
cadherin–catenin complex and the calcium-independent nectin–afadin 
complex. Classical cadherins are single-pass, transmembrane glycoproteins 
that share a common structure composed by five characteristic extracellular 
cadherin (EC) repeats and an intracellular region containing a catenin-binding 
domain. EC domains bind calcium (Ca2+) undergoing a Ca2+-dependent 
conformational change that allows homodimerization. Through extracellular 
interactions with E-cadherins on a neighboring cell, opposing cadherin dimers 
can integrate the actin cytoskeleton. Stabilization of intercellular adhesion 
requires the cytoplasmic domain of E-cadherin, which binds to β-catenin that, 
in turn, binds α-catenin, recruiting a number of cytoskeletal proteins essential 
in polymerizing and organizing actin cables to seal membranes (Halbleib and 
Nelson, 2006; Brasch et al., 2012). The other basic adhesive unit composing 
the AJ is the nectin–afadin complex. Nectins are a family of calcium 
independent immunoglobulin-like cell–cell adhesion molecules, with the 
ability of homophilic and heterophilic interaction (reviewed in (Rikitake et al., 
2012)). Four family members (nectin 1-4) share a common structure 
characterized by an extracellular region with three immunoglobulin-like loops, 
a single membrane-spanning region and a cytoplasmic tail that take contact 
with afadin. Through their immunoglobulin-like loops nectins contact each 
other on the surface of the adjacent cells and in particular, nectin-1 can interact 
with nectin-3 and nectin-4, whereas nectin-2 is able to interact with nectin-3. 
Afadin, a F-actin binding protein that connect nectins to the actin cytoskeleton, 
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is also able to directly bind α-catenin to mediate the assembly of multiple 
complexes (Tachibana et al., 2000; Yokoyama et al., 2001).  
   Different groups demonstrated that p63 regulates different components of AJ. 
Indeed, Christiano and coworkers found that p63 directly interacts with two 
distinct regions of the human CDH3 promoter but not CDH1 (Shimomura et 
al., 2008) whereas McDade and colleagues demonstrated a direct p63 binding 
on the human PVRL1 promoter in human keratinocytes, and its responsiveness 
to p63 in heterologous cells (McDade et al., 2012). More recently we 
demonstrated that Pvrl1 expression is impaired in p63 depleted keratinocytes 
and in p63 null embryonic skin, and that Pvrl1 is a p63 direct target gene 
(Mollo et al., 2014). Interestingly, Pvrl1 and Pvrl4 expression were reduced in 
keratinocytes derived from a conditional mouse model for AEC syndrome and 
from human patients, indicating that Pvrl4 expression is affected by mutant 
p63, possibly through a mechanism dependent on the transcription factor Irf6, 
as shown in Irf6 depleted keratinocytes (Mollo et al., 2014). 
   Tight junctons are responsible for intercellular sealing and the 
compartmentalization of extracellular environments, exhibiting ion and size 
selectivity (reviewed in (Van Itallie and Anderson, 2014)). They form an 
almost continuous plasma membrane contact zone around each cell and are 
composed of two kinds of tetraspan transmembrane proteins, occludin and 
members of the claudin family and single span transmebrane proteins JAMs 
that act as regulators of tight junction assembly in epithelia.  
   It is reported that Cldn1 is a p63 direct target gene (Rinne et al., 2007; 
Lopardo et al., 2008), indeed p63 deficiency leads to strong inhibition of Cldn1 
expression both in p63 null mice and in mouse keratinocytes. Among the 
claudins, Cldn3 and Cldn7 are expressed in simple epithelia and are ectopically 
expressed in p63-depleted keratinocytes and in p63 null embryonic epidermis 
(De Rosa et al., 2009). Consistent with these data in mouse, CLDN7 is 
overexpressed in AEC patient keratinocytes in conjunction with reduced 
CLDN1 expression (Zarnegar et al., 2012; Shen et al., 2013), suggesting that 
an unbalance among claudins in AEC patients may be at the origin of some of 
the observed defects. This possibility is supported by previous studies showing 
that ectopic overexpression of periderm-specific claudin 6, in the upper layers 
of the epidermis induces a phenotype that is identical to Cldn1 null mice 
(Morita et al., 1998; Turksen and Troy, 2002), indicating that unbalanced 
claudin expression might alter TJ function. Thus a functional p63 is required 
for appropriate claudin expression in the epidermis, although the functional 
significance of this finding in AEC syndrome is unclear at the moment. 
 
1.7 The Notch pathway  
 
   Stratification of the epidermis is a tightly controlled process that requires the 
orchestrated action of different key signal transduction pathways, such as e.g. 
Wnt/ -catenin, Notch, TGF-  and NF- B (Koster and Roop, 2007; Blanpain 
and Fuchs, 2009). In particular, Notch signaling has a crucial role in the proper 
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stratification and development of the epidermis and its appendages (Vauclair et 
al., 2005; Moriyama et al., 2008). Keratinocytes require Notch signaling to 
downregulate basal genes and induce spinous layer markers, thereby switching 
from proliferation to differentiation (Rangarajan et al., 2001; Blanpain et al., 
2006; Blanpain and Fuchs, 2009).  
   p63 expression counteracts the ability of Notch1 to restrict growth and 
promote differentiation in keratinocytes.  
   In mammals, there are four Notch receptors (Notch1-4) and five canonical 
ligands of the Delta-Serrate-Lag (DSL) type (Jag1 and Jag2 and delta-like 1 
(Dll1), Dll3 and Dll4) (reviewed in (D'Souza et al., 2010)).  
   Notch receptors are a single pass trans-membrane protein expressed on the 
cell surface as heterodimers composed of a large extracellular domain non-
covalently linked to the intracellular domain. The extracellular domain of all 
Notch receptors contains epidermal growth-factor-like repeats (EGFLR) and 
three LIN Notch (LNR) repeats. The intracellular domain contains the RAM23 
domain and seven Ankyrin/CDC10 repeats (ANK), necessary for protein- 
protein interactions. In addition, Notch receptors 1-3 contain two nuclear 
localization signals (NLS), in contrast Notch4 contain only one NLS. The NSL 
target the intracellular domain to the nucleus where the transcriptional 
activation domain (TAD) activates downstream events (Kopan, 2012).  
   Notch receptors are cleaved by protein convertases during exocytosis at site 1 
(S1), which regulates their trafficking and signaling activity (Jarriault et al., 
1998; Gordon et al., 2009). The response of the Notch receptors to different 
subfamilies of ligands and the subsequent activated downstream pathway are 
regulates by a series of post-translational modifications. Indeed, they can be 
glycosylated by glycosyltransferases such as Fringe during passage through the 
Golgi whereas, E3 ubiquitin ligases (e.g., Deltex and Nedd4), Numb, and  -
adaptin, regulate the steady-state levels of the Notch receptor at the cell surface 
(Fig. 7). 
   The signaling pathways initiated in response to Notch ligands are known as 
the canonical and non-canonical Notch signaling pathway. In canonical Notch 
signaling, a Notch transmembrane receptor interacts extracellularly with a 
canonical Notch transmembrane ligand on a contacting cell, initiating 
proteolytic cleavage of the receptor by metalloprotease of ADAM/TACE 
family which removes the Notch extracellular domain by cleaving at site 2 
(S2);  -secretase then cleaves Notch within its transmembrane domain at site 3 
(S3) to release various forms of the NICD, the Notch intracellular domain of 
the receptor. Notch ICD then translocates to the nucleus where it interacts with 
a CBF1/Suppressor of Hairless/LAG-1 (CSL) family DNA-binding protein (or 
recombination signal binding protein for immunoglobulin kappa J region 
(RBPJ- ) in mammals) and initiates the transcription of Notch target genes 
(Fig. 7). Non-canonical Notch signaling differs from canonical signaling in that 
it can be initiated by a non-canonical ligand, or may not require cleavage of the 
Notch receptor.  
   The role of Notch in epidermal development and maintenance has been the 
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subject of number studies. Ablation of Notch signaling during skin 
embryogenesis invoked early postnatal death mainly due to a disturbed 
epidermal barrier (Demehri et al., 2008). Postnatal knockout of Notch-1 led to 
a hyperproliferative epidermis, hair loss and epidermal cyst formation (Nicolas 
et al., 2003; Blanpain et al., 2006). Loss of epidermal Notch-1 or Notch-
1/Notch2 disturbed skin homeostasis and resulted in inflammatory skin disease 
(Demehri et al., 2009; Dumortier et al., 2010). Mice with impaired Notch-1 
signaling developed skin tumors, indicating a tumor suppressor function for 
Notch-1 in the skin (Nicolas et al., 2003; Proweller et al., 2006).  All these 
studies supported the idea that Notch is the main regulator of skin 
differentiation since the perturbation of this pathway leads to dramatic changes 
in epidermis structure and function.  
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Figure 8. Notch signaling. Notch proteins are synthesized as single precursor 
proteins, which are cleaved in the Golgi by a Furin-like convertase at site S1. 
Cleavage at S1 generates two subunits held together noncovalently. EGF-like 
repeats present within the extracellular domain of the receptors are 
glycosylated by Fringe proteins in the Golgi before receptors are transported to 
the cell surface. Notch signaling is initiated by ligand–receptor interaction, 
which induces a second cleavage at site S2 (close to the transmembrane 
domain) mediated by ADAM-type metalloproteases, followed by a third 
cleavage at S3 within the transmembrane domain mediated by the g-secretase 
activity of a multiprotein complex containing presenilins. This last proteolytic 
cleavage liberates the cytoplasmic domain of Notch receptors (NICD), which 
translocate to the nucleus and bind to the transcription factor RBP-J, 
converting it from a transcriptional repressor into a transcriptional activator by 
recruiting co-activators to induce target gene expression (Adapted from Kopan 
R., 2012).  
	 	
2. AIM OF THE STUDY  
    
   My research activity, during the last three years, focused on the elucidation 
of the molecular mechanisms at the basis of epidermal defects and skin 
fragility in AEC syndrome. To these aim I characterized a newly generated 
conditional mouse model for the AEC syndrome. 
 
 
 
 
	 	
 
3. MATERIALS AND METHODS 
 
 
3.1 Generation of conditional p63+/FloxL514F mouse model  
 
   We recently generated a conditional knock-in model (p63+/FloxL514F), in which 
the L514F mutation is expressed only in the presence of the CRE recombinase.  
The knock-in/replacement strategy was designed to replace the wild-type 
amino acid leucine encoded by codon 514 with a sequence coding for 
phenylalanine in the p63 protein in murine embryonic stem (ES) cells by 
homologous recombination.  The targeting contruct contained two LoxP 
flanking fused wild-type exons 13 and 14 placed upstream a neomycin 
resistence cassette flanked by FRT loci and a mutant exons 13 followed by the 
exon 14 and an immunoepitope tag (3xFlag) at the end of it. 
 
3.2 Mouse genotyping 
 
   Conditional knock-in p63+/FloxL514F, p63FloxL514F/FloxL514F, K14Cre;p63+/FloxL514F 
(+/L) and K14Cre;p63FloxL514F/FloxL514F (L/L) were genotyped by PCR using 
genomic DNA isolated from mouse tails. 
Oligonucletide primers used for PCR:  
Conditional knock-in p63+/FloxL514F, p63FloxL514F/FloxL514F   
 
Forward primer (5’-3’) Reverse primer (5’-3’)
CAGCGTATCAAAGAGG
AAGGAGA 
AGCCAGAATCAGAATCAGGTG
AC 
 
The expected bands were of 250bp for the wild-type mice, 337bp for the 
mutant homozygous mice and both for the heterozygous ones. 
 
To distinguish the presence of Cre-recombinase in p63 heterozygous and 
homozygous mice we used the following primers for PCR: 
 
Forward primer (5’-3’) Reverse primer (5’-3’)
AGGGATCTGATCGGGA
GTTG 
CTTGCGAACCTCATCACTCG 
 
 
Western blot  
 
   For immunoblotting cells were lysed in sample buffer (10% glycerol, 0.01 % 
Bromophenol Blue, 0.0625 M Tris-HCl pH 6.8, 3 % SDS, 5 % 
ßmercaptoethanol) supplemented with protease inhibitors. For immunoblotting 
of epidermal extracts, epidermis was isolated from dermis by producing a 
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termic shock at 55°C or by floating skin biopsies, epidermis side up, in a 
Dispase solution. After isolation from dermis, epidermis was snap frozen in 
liquid nitrogen and then homogenized with a tissue lyser in lysis buffer 
supplemented with phosphatase and protease inhibitors. Proteins were run on a 
denaturing SDS-PAGE gel and subsequently transferred to Immobilon-P 
transfer membranes (Millipore) probed with primary antibodies and detected 
by chemiluminescence (ECL, GE Healthcare Life Sciences). Antibodies used 
for immunoblotting were: p63 (4A4 Santa Cruz Biotechnology), Cdh1 (BD 
Bioscience), krt5, krt14, krt1, krt10, ivl, lor (all Covance), krt15 (a gift from 
doct. Langbein), Nectin1 (Santa Cruz Biotechnology), b-actin (Santa Cruz 
Biotechnology), Notch1 (Santa Cruz Biotechnology), ERK-1 (Santa Cruz 
Biotechnology).  
 
Real-time RT-PCR 
 
   Mouse epidermis was isolated from dermis by digestion with Dispase 
solution. Total RNA was extracted from primary keratinocytes or epidermis 
using TRIzol reagent (Invitrogen). cDNA was synthesized using SuperScript 
Vilo (Invitrogen). Two-step real-time reverse transcription RT-PCR was 
performed using the SYBR Green PCR master mix in an ABI PRISM 7500 
(Applied Biosystems). Levels of the target genes were quantified using specific 
oligonucleotide primers and normalized for Actin (ß-actin) or RPLP0 
expression. 
 
Oligonucletide primers used for Real-Time RT-PCR on mouse samples: 
 
Gene Forward primer (5’-3’) Reverse primer (5’-3’) 
ß-actin CTAAGGCCAACCGTGA
AAAGAT 
 
GCCTGGATGGCTACGTACATG 
 
p63 wt 
 
ACTCTCCATGCCCTCCA
C 
 
GAGCAGCCCAACCTTGCT 
 
p63 
L514F 
 
ACTCTCCATGCCCTCCA
C 
GAGCAGCCCAACCTTGCA 
 
Krt5 
 
CAACGTCAAGAAGCAG
TGTGC 
 
TTGCTCAGCTTCAGCAATGG 
 
Krt14 ACCACGAGGAGGAAAT
GGC 
 
TGACGTCTCCACCCACCTG 
 
Dsc3 CCACCGTCTCTCACTAC
ATGGA 
 
TGTCCTGAACTTTCATTATCAGT
TTGT 
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Dsp CACCGTCAACGACCAG
AACTC 
 
GATGGTGTTCTGATTCTGATGT
CTAGA 
 
Pvrl1 TTCTTCCTCCCAGGCAC
TCA 
AAGCCATACATGGAGTCGTTCA 
Pvrl2 TGCTGCCAGTGACCCTC
TCT 
CATCATAGCCGGAGATGGATAC
T 
Pvrl3 AAACCCTCCACCCTTCA
AGTCC 
CAATAAACCATCAGGCCATTGT
C 
Pvrl4 GGCATCGTTTACAGGCC
AAT 
AGCACCACTGTCACTACGTCAG
A 
Mllt4 TCGGGAAGCGAGAGAG
AAAC 
GCTCCAGAACTGCCAGGTAAGT 
 
Cdh1 GGGCTGGACCGAGAGA
GTTAC 
AAGCCTTCACCTTGAAGGTCAG 
Notch1 ATGGAGGGAGGTGCGA
AGT 
ATTGGAGTCCTGGCATCGTT 
Jag2 CCTCCTCCTGCTGCTTT
GTG  
TCTGGATCAGGCTGCTGTCA  
 
Tslp GCCAGGGATAGGATTG
AGAGTATAGT 
GACTGTGAGAGCAAGCCAGCTT 
 
Alox12 CCTTGGCCGAGAAGGTT
CA 
GCGCCATTGAGGAACTGGTA 
 
Hes1 CTGTGAGGTCAGGCCAG
CTT 
AGGCCCATGGAAAATGAGC 
 
 
Oligonucleotide primers for Real Time RT-PCR on human samples 
Gene Forward primer (5’-3’) Reverse primer (5’-3’) 
RPLP0 GACGGATTACACCTTC
CCACTT  
GGCAGATGGATCAGCCAAGA  
PVRL1 
 
CCCTACGGGCAATCGA
GAA  
GGTGGGTTTGGCCATCAC  
PVRL4 ATGCTCAAGTGCCTGA
GTGAAG  
TCCAGCCGTGTCCAGTTGTA  
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KRT5 CCTCAACAATAAGTTT
GCCTCCTT 
GCAGCAGGGTCCACTTGGT 
 
KRT14 GGATGACTTCCGCACC
AAGT 
TCCACACTCATGCGCAGGT 
 
 
Primary keratinocytes and cell cultures. 
 
   Newborn mice were placed in petri dishes with ice and inserted in an ice 
bucket. After 30-45’ newborn mice were washed twice with 70% ethanol and 
twice with water to remove ethanol completely. Using sterile techniques, mice 
tails and limbs were amputated with sterile surgical scissors. Single skin was 
carefully separated from the rest of the viscera and flattened in a empty 6 well 
dish with the dermis facing down; 2 ml of Dispase solution (0.5mg Dispase-
GIBCO, Na-bicarbonate 0.75%, Hepes 10mM, Antibiotic-Antimycotic in PBS) 
were added to each 6 well dish and incubated o/n at 4 °C. Next day epidermis 
was separated from the dermis and placed in a 100mm Petri dish in 2ml (for 
each epidermis) of 0.125% trypsin- 0.1mM EDTA. Epidermis was minced with 
tweezers and scissors until was reduced in very small fragments and placed at 
37°C for 5-8 minutes. Then trypsin was inactivated with DMEM+10% FBS 
and filtered by applying it to cell strainer in order to remove the floating 
particles. Cells were placed into the centrifuge for 5 minutes at 1000 rpm; then 
were plated on collagen coated plates (1.2x106 cells/ml) and incubated at 
34°C, 8% CO2. Primary mouse keratinocytes were isolated from newborn 
mice and cultured under low calcium conditions (0.05 mM) or treated with 
2mM calcium chloride as previously described (Antonini et al., 2010).  
   Human keratinocytes obtained from AEC patients Q11X and T533P (kindly 
provided by J. Zhou, (Ferone et al., 2013)), as well as control keratinocytes 
obtained by unaffected individuals were plated at a density of 104cells/cm2 and 
cultured in KBM Gold medium (Lonza) till they reach confluency. Confluent 
cells were treated with 0.3mM calcium for subsequent RNA analysis.  
   Knockdown was achieved by transient transfection of 100nM small 
interfering RNA (siRNA) for pan-p63, ∆Np63 (De Rosa et al., 2009), Irf6 
(Mm_Irf6_2; Qiagen) or negative control (Invitrogen).  
   Normal human epidermal keratinocytes (NHEK-Neo, Lonza; Cat. No. 
00192907) were plated at a density of 104cells/cm2 and cultured in KBM Gold 
medium (Lonza) until they reach confluence. p63 and ∆Np63 knockdown were 
obtained by transient transfection of 100nM small interfering RNA (siRNA) 
for pan-p63 (5’- CAGAACACACAUGGUAUCCAGAUGA-3’, Stealth RNAi 
Invitrogen), ∆Np63 (De Rosa et al., 2009) or negative control (Invitrogen). 
 
Skin Barrier Assays 
   
   To perform X-gal staining, unfixed, untreated newborn mice or embryos 
were washed in PBS and then incubated overnight at 37°C in 5-bromo-4- 
chloro-3-indlyl-b-D-galactopyranoside (X-gal) reaction mix (100 mM NaPO4, 
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1.3 mM MgCl2, 3 mM K3Fe[CN]6, 3 mM K4Fe[CN]6, and 1 mg/ml X-gal 
[pH 4.5]). At pH 4.5, the skin exhibits endogenous b-galactosidase activity, so 
increased X-gal staining indicates epidermal permeability to X-gal, a sign of 
compromised barrier function (Hardman et al., 1998). 
 
Gene expression microarrays 
   
   We measured the differential expression of 22000 RNA on freshly isolated 
epidermis from three mutant versus three wild-type newborn mice. We 
hybridized the RNA samples to the Affymetrix Mouse Genome 430A 2.0 
chips. We processed the microarrays using the RMA algorithm. False 
Discovery Rate (FDR) correction was perfomed on the estimated p-value to 
correct for multiple hypothesis test.    
 
Histology and Immunostaining  
 
   Dorsal skin was dissected, fixed in 4% paraformaldehyde (PFA) and 
embedded in paraffin or in OCT, from which 7 μm sections were cut and 
stained with Haematoxylin and Eosin (H&E) and immunofluorescence 
according to standard methods. For paraffin sections, permeabilization for 
antigen retrieval was performed by microwaving samples in 0.01 M citrate 
buffer at pH 6.0. The following antibodies were used: keratin 6, keratin 5, 
keratin 14 (Convance), p63 (4A4, Santa Cruz Biotechnology), Ecadherin 
(Zymed laboratories-Invitrogen), guinea pig antibody to keratin 15 (a gift from 
doct. Langbein), FLAG M2 (Sigma), Col7a1 (Sigma), Dsp and Dsc3 (a gift 
from doct. H. Thomason)  
The following secondary antibodies were used for immunofluorescence 
staining: Alexa Fluor ® 488 goat anti-mouse (Invitrogen), Alexa Fluor ® 594 
goat anti-rabbit (Invitrogen), Alexa Fluor ® 594 goat anti-rat (Invitrogen). 
Fluorescent signals were monitored under a Zeiss Axioskop2 plus image 
microscope or under a Zeiss confocal microscope LSM510meta. 
 
Chromatin Immunoprecipitation (ChIP)  
 
1 x 10^6 keratinocytes were fixed with 1% formaldehyde in growth medium at 
37°C for 10 min. Extracts were sonicated using BIORUPTOR (Diagenode) to 
obtain DNA fragments ranging from 400 to 800 bp in length. Chromatin was 
immunoprecipitated as in the Upstate protocol (http://www.upstate.com). 
Immunoprecipitation was performed using anti-p63 (H-137; Santa Cruz 
Biotechnology) and anti-ERK-1 (K23; Santa Cruz Biotechnology) antibodies 
as negative control. Real-time PCR was performed using the SYBR Green 
PCR master mix in an ABI PRISM 7500 (Applied Biosystems). 
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Oligonucleotide primers for ChIP analysis on human genomic DNA. 
 
Gene Forward primer (5’-3’) Reverse primer (5’-3’) 
PVRL1 
reg 1 TGAGCCTGTAGGACCAGAATCA
TTTCCCACTCAAGCTGTGTC
TCT 
PVRL1 
reg 2 TCTGCCCAACACGAATCTATCA 
CTGAAACCCCGACAAGTCT
GA 
 
Oligonucleotide primers for ChIP analysis on mouse genomic DNA. 
 
Gene Forward primer (5’-3’) Reverse primer (5’-3’) 
Pvrl1 
reg 1 CTGTGTCTCCAGGACGTGTCA 
GCACAGCCAAGCCTGTAG
GA 
Pvrl1 
reg 2 GAAAGACCCCACACTTGAAACTG TCCTCCCGGGCTTCCTT 
 
Dispase-based dissociation assay 
 
   Mechanical integrity of cell monolayers was assessed as described previously 
(Calautti et al., 1998; Huen et al., 2002). Keratinocytes were grown to 
confluence in low-calcium medium containing 0.05 mM CaCl2 and switched 
to medium containing 0.6 mM CaCl2 for 1–3 days. At that time, keratinocyte 
sheets were lifted from the culture dishes by treating with 2.4 U/ml Dispase II 
(Roche) for 30 min at 378C. Intact sheets were transferred to 15 ml conical 
tubes containing 5 ml of PBS. Tubes were placed in a rack and inverted were 
inverted on a rotor at 0.28 g for 30–50 inversion cycles. Cellular fragments 
were transferred to 35 mm tissue culture plates and counted using a dissecting 
microscope. 
 
Adenoviral infection  
 
   Mouse primary keratinocytes were infected after 4-5 days of plating, when 
they reached confluence. Adenovirus carring the GFP or the NIC (provided by 
OKAIROS) at MOI 100 were diluted in 250 L for 12-well of LCM without 
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serum and EGF. After 2 hours of infection, supplemented medium was added 
and left o/n at 34°C.  
 
Retroviral infection  
 
   Mouse primary keratinocytes were infected the day after plated with 
retroviruses carrying the GFP (PINCO), Notch1 or MAML1 for 2 hours. After 
the infection cells were washed with PBS and were cultured in LCM4% for a 
week at 34°C. 
 
	 	
4. RESULTS  
 
   
4.1 Epidermal-specific L514F mutation results in severe skin phenotype. 
 
   To dissect the molecular defects underlying AEC syndrome and to overcome 
the lethality of the constitutive AEC mouse model (Ferone et al., 2012), we 
generated a conditional knock-in p63floxL514F mouse model, in which the L514F 
mutation was expressed only in the presence of the CRE recombinase. The 
knock-in strategy was designed to replace the wild-type amino acid leucine 
encoded by codon 514 with phenylalanine in the p63 protein in murine 
embryonic stem (ES) cells by homologous recombination (Fig. 9A). To study 
the adult phenotype we crossed p63+/floxL514F mice with a knock-in mouse 
expressing Cre by E17.5 in epidermis and hair follicle under the control of the 
endogenous keratin 14 (K14) promoter (K14-Cre ∆neo) (Huelsken et al., 2001) 
to obtain both the heterozygous and the homozygous model (K14-
Cre;p63+/floxL514F and K14-Cre;p63floxL514F/floxL514F). The expression of the 
mutant protein was confirmed in K14-Cre;p63+/floxL514F (+/L) mutant newborn 
mice by immunofluorescence analysis with FLAG antibody, which specifically 
recognizes the mutant protein (Fig. 9B). At birth a nearly uniform expression 
of the mutant protein in the interfollicular epidermal cells was observed by a 
co-staining with FLAG antibody and Krt14 antibody that marked the basal 
layer of the epidermis and the hair follicle (Fig. 9B). The wild-type and mutant 
alleles were also revealed by quantitative real time RT-PCR (qRT-PCR) and by 
immunoblot in both heterozygous +/L and homozygous K14-Cre; 
p63floxL524F/floxL514F (L/L) mutant mice. qRT-PCR and immunoblot analysis 
confirmed that by post-natal day 3 (P3) wild-type p63 was virtually absent in 
L/L epidermis and about 50% expressed in +/L epidermis (Fig.9 C, D). The 
expression of mutant p63 mRNA and protein was more abundant in mutant 
than in wild-type epidermis, consistent with the previously reported p63 
accumulation in the skin of AEC patients and in agreement with our previous 
data (Moretti et al., 2010; Browne et al., 2011; Ferone et al., 2012).     
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Figure 9. Generation of AEC mutant mice: A) Gene targeting strategy used 
to generate the p63+/L514F knock-in mice. The L514F mutation is indicated with 
* The targeting contruct contained two LoxP flanking wild-type exons 13 and 
14 fused together and placed upstream a neomycin resistence cassette flanked 
by FRT loci and a mutant exon 13 followed by the exon 14 and an 3xFLAG 
epitope tag at the end of it. B) Double immunofluorescence for Krt14 and Flag 
revealed that all the cells of the basal layer of the epidermis in AEC mutant 
newborn mice are positive for the mutant protein. C) Real-Time RT-PCR 
performed on RNA from controls (+/+), heterozygous (+/L) and homozygous 
(L/L) epidermis at P3, revealed the proper expression of mutant allele. D) 
Immunoblotting of total cell extracts from controls (+/+), heterozygous (+/L) 
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and homozygous (L/L) neonatal epidermis (P3) using antibodies against p63 
and cdh1 as loading control.  
 
   +/L mice showed no gross abnormalities and were characterized by striped 
hair and partial hair loss (Fig. 10A). At the histological level +/L skin appeared 
hypoplastic at birth with a reduction of keratin 15 (Krt15) expression at later 
stage, consistent with the previous generated data in the constitutive mouse 
model (Fig. 10B and C) (Ferone et al., 2012).  
   At later stages hypoplasia of the epidermis and hypercellularized dermis was 
visible in +/L skin respect to controls (Fig. 10B). 
 
 
 	 34	
 
Figure 10. Characterization of +/L mouse model. A) Photographs were 
taken of +/L and L/L at 30 days. B) H&E of back skin of +/+ and +/L mice at 
P2 revealed a slight hypoplasia that is maintained also at P50, when dermis 
became hyper-cellularised and fat layer diminished. C) Double 
immunofluorescence for p63 and Krt15 of back skin of +/+ and +/L mice at P7 
revealed a decreased staining of Krt15 in the interfollicular epidermis respect 
to the control. 
 
Interestingly, L/L mice were indistinguishable from their wild-type littermates 
at birth, but in few cases, 3-5 days old pups (P3-P5) had areas of severe skin 
erosion with an otherwise apparently normal phenotype. Starting from P5-P7, 
mutant mice developed a progressively severe phenotype, characterized by 
skin erosions, skin crusting and hair loss. About 75% of mutant mice died 
between P10 and P20, although some lived up to 12 months. A significant 
reduction of body weight was observed at different time points (Fig.11 A, B). 
 
 
  
Figure 11. Phenotype of AEC mutant mice: A) Photographs were taken from 
L/L mice at different stages, as indicated in the figure. Five days after birth L/L 
mice showed a strong phenotype characterized by skin erosion, skin crusting, 
hair loss and ulcerations that worsen throughout their life. B) Survival curve of 
L/L, +/L and +/+ mice (n= 184); on the left side body weight at p10 and p20 of 
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L/L, +/L and +/+ mice, (p10: n= 72 p-value=2.6847E-07; p20: n= 47 p-value= 
6.38948E-06). 
 
4.2 Epidermal blistering and defective adhesion molecules in AEC mice. 
    
   Although the visible phenotype appeared after many days after birth, 
histological analyses of the back skin from L/L mice and littermates controls 
revealed epidermal hypoplasia at P0 with consistently thin epidermis and 
dermis. Blistering skin lesions, localized only in focal points of mutant 
epidermis, were observed both between the basal and suprabasal layers and 
between basal layer and basal lamina, as previously observed for the 
constitutive mouse model and consistent with a fundamental role of p63 in cell 
adhesion (Fig. 12A)(Ferone et al., 2013; Ferone et al., 2015). Epidermal 
blisters were also accompanied by both acantholysis and cytolysis, as display 
by the immunostaining for basal keratin Krt14 that revealed both loss of 
cohesion between keratinocytes and cell disruption (Fig. 12B).  
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Figure 12. Epidermal blistering and skin fragility in AEC mutant mice. A) 
H&E staining of dorsal skin of L/L mice at P0. Mutant epidermis was thinner, 
with less developed hair follicles and focal gaps were visible in L/L epidermis. 
B) Immunofluorescence analysis of dorsal skin for Krt14 revealed that in L/L 
skin focal blistering were accompained by acantholysis and cytolysis.  
 
   Given the presence of skin blistering, we evaluated the epidermal barrier 
integrity using a permeability assay based on X-gal substrate. We observed no 
abnormalities at E17.5 but newborn mutant mice showed focal gaps in the 
epidermis, consistent with the focal skin blistering observed at histological 
level (Fig. 13A and B). 
 
  
Figure 13: Focal epidermal barrier disruption in AEC mutant mice. A) 
Barrier assay at E17.5 and P0 on AEC mutant and control mice revealed the 
presence of focal gaps in mutant mice at P0 (p-value=1.58596E-09;n= 34). B) 
H&E of focal gaps revealed by barrier assay. 
 
   Because epidermal lipids are crucial to form the protective barrier of the skin 
in the stratum corneum we stained P3 skin sections with the lipophilic dye Nile 
Red. No significant differences in epidermal lipid content were observed. 
Impaired integrity of the cornified envelope (CE) has been linked to skin 
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barrier defects (Sevilla et al., 2007) therefore CE preparations derived from 
back skin of P3 mice was analyzed. Also this analysis revealed no evident 
differences in mutant versus control preparations (data not shown).  
 
4.3 Skin blistering in AEC mouse model is due to alteration in different 
adhesion molecules. 
 
   Since epidermal blisters may be caused by defects in adhesion molecules and 
we previously observed that in both the AEC patients and the constitutive AEC 
mouse model desmosomes were impaired, we analyzed the expression of 
desmosomal genes in our mouse model (Ferone et al., 2013). 
Accordingly with previous data, we observed a strong reduction of several 
desmosome components in L/L keratinocytes, with the most significantly 
affected desmosome protein being desmoglein 1 (Dsg1), desmocollin 3 (Dsc3) 
and desmoplakin (Dsp) (Fig.14A).  
   At the functional level, desmosome defects are associated with weaken cell–
cell adhesion and reduced mechanical stress resistance of keratinocyte 
monolayers. To determine whether defects in desmosome gene expression 
resulted in weakened cell–cell adhesion, the mechanical stress resistance of 
mutant keratinocyte monolayers in culture was compared with controls. 
Consistent with reduced expression of several desmosomal proteins, cell sheets 
of mutant keratinocytes generated under high-calcium conditions were 
significantly less resistant to mechanical stress than control wild-type 
keratinocytes in a shearing assay (Fig. 14B).  
   Interestingly, immunofluorescence analysis revealed that also the cellular 
localization of desmosomal protein Dsp and Dsc3 was lower and abnormal in 
cultured mutant keratinocytes respect to controls (Fig.14C). These data were 
obtained in mouse keratinocytes, whereas mutant epidermis of the conditional 
mouse model, in spite of focal skin fragility, expressed properly desmosomes 
(data not shown) thus indicating that other mechanism may be account for the 
observed epidermal blistering in mutant mice.   
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Figure 14. Desmosomes expression and mechanical resistance in vitro in 
AEC keratinocytes. A) Real-time RT-PCR on mouse keratynocytes derived 
from L/L and control mice harvested under basal (low Ca++) and differentiating 
conditions (high Ca++, 2mM). B) Detached monolayers of keratinocytes were 
subjected to mechanical stress, and resulting fragments of the cell sheet were 
imaged and counted. Quantitative evaluation of particles generated in the 
experiment is shown on the right. C) Immunofluorescence analysis on mouse 
primary keratinocytes isolated from control or mutant mice cultured for one 
week on glass slides. Cells were treated (Dsp and Dsc3) with 2mM calcium 
chloride to induce differentiation for 24 hours.  
 
   Beside desmosomes, adherens junction components Pvrl1 and Pvrl4 were 
expressed in epidermis and are fundamental for cell-cell cohesion. We 
analyzed the expression of PVRL1 and PVRL4 in human keratinocytes derived 
from individuals affected by AEC syndrome. Interestingly, both PVRL1 and 
PVRL4 were strongly reduced (Fig. 15A). Similar results were obtained in 
keratinocytes derived from AEC mouse model respect to control. Both Pvrl1 
and Pvrl4 were significantly lower in mutant keratinocytes versus controls 
under basal and differentiating conditions (Fig. 15B).  
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Figure 15. PVRL1 and PVRL4 expression in p63 mutant keratinocytes: A) 
PVRL1 and PVRL4 mRNA expression levels in human keratinocytes derived 
from two affected individuals (AEC1 and AEC2) and controls (ctr1 and ctr2) 
harvested under differentiating (0.3 mM Ca++) conditions. Data are normalized 
for RPLP0 mRNA levels and are represented as mean ± SD normalized mRNA 
levels. B) Pvrl1 and Pvrl4 mRNA expression in L/L keratinocytes harvested 
under basal (low Ca++) and differentiating conditions (high Ca++, 2mM).  Pvrl1 
mRNA levels were significantly decreased both under basal (*p-value=8.13E-
05; n=14) and differentiating conditions (*p-value=9.7E-05; n=10). Similarly 
Pvrl4 mRNA levels were significantly decreased under basal (*p-value=0.012; 
n=14) and differentiating conditions (*p-value= 0.008; n=6). Data are 
normalized for β-actin mRNA levels and are represented as mean ± SD.   
 
   Skin blistering could be due to alterations in different components of cell-cell 
and cell-matrix adhesion. Indeed further analysis revealed a strong reduction 
also in cell-matrix adhesion molecule collagen VII (Col7a1) (Fig. 16), thus 
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reinforcing the idea that skin fragility in AEC mouse model was due to 
alteration of different adhesion molecules.  
 
 Figure 16: Skin blistering in the AEC mouse model. A) 
Immunofluorescence on frozen section of dorsal skin at P3 for Collagen VII 
revealed a strong reduction of the protein in AEC mutant epidermis respect to 
the controls. 
 
 
   Since it has been suggested from the literature that the overall function of 
epidermal intermediate filaments (IF), also known as keratins, is to impart 
mechanical integrity to the cells, without which, the cells become fragile and 
prone to rupturing, we analyzed the expression levels of keratins in epidermis 
of AEC mutant and control mice. Keratins represent an apparatus through 
which the cell becomes more resistant to mechanical stress, on the other hand 
they are an index of differentiation of the epidermis, being expressed in a 
specific manner by the different layers of the epidermis. 
   At P3 epidermal differentiation was critically altered in L/L mice since 
expression of Krt5, Krt10 and Krt15 decreased in mutant mice respect to the 
controls. In contrast, late differentiation markes such as loricrin and involucrin 
are properly expressed in mutant mice (Fig.17A).  In accordance with the 
alteration of keratins of the basal layer, ultrastructural analysis demonstrated 
reduces keratin bundles in the basal layer of the epidermis of mutant mice 
compared to controls (Fig. 17B). Importantly reduced KRT5 was observed also 
in human samples derived from AEC patients both at the RNA and protein 
levels (Fig. 17C).  
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Figure 17. Expression of keratins and other differentiation markers in the 
AEC mouse model. A) Immunoblotting of total cell extracts from neonatal 
epidermis of L/L and +/+ mice using antibodies against the indicated 
differentiation markers. -actin was used to normalize samples. B) Tissue-
electron microscopy (TEM) of newborn skin. C) Immunofluorescence analysis 
of human AEC patients and controls with antibodies against KRT5 and 
KRT14.  
 
   Interestingly, we observed that both Krt5 and Krt14 expression, that were 
known p63 target genes (Romano et al., 2009), was strongly downregulated in 
p63 knockdown and in AEC mutant keratinocytes (Fig. 18 A and B), whereas 
in AEC mutant epidermis only Krt5 was significantly affected indicating that 
in vivo p63 plays a crucial function in Krt5 regulation (Fig. 18 C). 
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Figure 18 Differential regulation of basal intermediate filaments. A) Real 
time RT-PCR for Krt5 and Krt14 in keratinocytes depleted of p63. Krt5 and 
Krt14 mRNA expression was strongly downregulated in p63 depleted 
keratinocytes as compared to controls (*p-value= 0.0002; n=4). Data are 
normalized for β-actin mRNA levels and are represented as mean ± SD 
normalized mRNA levels. B) Real-time RT-PCR for Krt5 and Krt14 in mouse 
keratynocytes derived from L/L and control mice harvested under basal (low 
Ca++) and differentiating conditions (high Ca++, 2mM). Data are normalized for 
β-actin mRNA levels and are represented as mean ± SD normalized mRNA 
levels. C) Real-time RT-PCR for Krt5 and Krt14 in mouse epidermis derived 
from L/L and control mice (*p-value= 0.0004; n=6). Data are normalized for β-
actin mRNA levels and are represented as mean ± SD normalized mRNA 
levels. 
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4.3.1 Adherens junction component Pvrl1 is a p63 target gene in skin.  
 
   A possible regulation of nectins by p63 has never been explored, although a 
putative genetic interaction between p63 and Pvrl1 has been postulated, since 
mutations in both genes lead to cleft palate (McGrath et al., 2001). Given that 
PVRL1 and PVRL4 associated syndromes have many features in common with 
those caused by p63 mutations, we investigated the possibility that p63 may 
regulate Pvrls expression in epidermis.  
   In p63 null embryonic epidermis Pvrl1 mRNA was strongly diminished in 
p63 null mice, whereas an equal amount of the other Pvrl genes, afadin (Mllt4) 
and E-cadherin (Cdh1) was observed (Fig. 19A). We next analyzed Pvrl1 
expression in primary mouse keratinocytes depleted for p63 or  Np63 using 
specific siRNA (Fig. 19B e C). In both p63 and  Np63 depleted keratinocytes 
Pvrl1 was significantly reduced both at the mRNA and protein levels as 
compared to controls, whereas Pvrl4 mRNA levels were not affected by p63 
knockdown, similar results were obtained in human (Fig. 19B and 18C).  
 
 
  
 
Figure 19: Pvrl1 is regulated by p63. A) Expression of the indicated genes 
was performed by real time RT-PCR in E16.5 p63 null (-/-) and controls (+/+) 
skin. Pvrl1 mRNA levels were strongly decreased in the skin of p63-/- mice 
compared to wild-type (*p-value=0.007; n=6). Data are normalized for β-actin 
mRNA levels and are expressed relative to controls. Error bars denote SD. B) 
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p63 mRNA expression in control mouse keratinocytes or in keratinocytes 
depleted of p63 or  Np63. Data are normalized for β-actin mRNA levels and 
are represented as mean of ± SD (left panel); immunoblotting analysis for 
nectin-1 and p63 in cell extracts depleted of p63 or ∆Np63, or controls (ctr). 
Data are normalized for β-actin protein expression (right panel). C) Real time 
RT-PCR for Pvrl1 in keratinocytes depleted of p63 or  Np63. Pvrl1 mRNA 
expression was strongly downregulated in p63 depleted keratinocytes as 
compared to controls (*p-value=0.002; n=8) whereas Pvrl4 expression is 
similar to control. Data are normalized for β-actin mRNA levels and are 
represented as mean ± SD normalized mRNA levels.  
 
To obtain further insights into the regulation of Pvrl1 by p63 we analyzed a 
genome-wide ChIP-seq analysis previously performed in human primary 
keratinocytes (Kouwenhoven et al., 2010) which revealed at least two strong 
p63 binding regions (p63BS1 and p63BS2) in the first intron of PVRL1. 
p63BS1 and p63BS2 were highly conserved in mammals and contained 
DNAse hypersensitive sites, consistent with their open chromatin 
state(Crawford et al., 2006; Nord et al., 2013). In addition p63BS2, and to a 
lesser extent p63BS1, were enriched for histone H3 acetylation on lysine 27 
(H3K27ac), a chromatin marks known to associate with active regulatory 
regions(Creyghton et al., 2010; Ernst et al., 2011; Rada-Iglesias et al., 2011). 
ChIP-qPCR analysis performed in human keratinocytes and in primary mouse 
epidermis confirmed that p63 efficiently bound both the identified regions and 
more strongly to p63BS2 in mouse epidermis (Fig. 20A and B). To gain further 
insights, we cloned p63BS2 upstream of the luciferase gene. Luciferase assays 
revealed that the p63BS2 activity was efficiently reduced upon p63 depletion 
in mouse keratinocytes (Fig. 20C). Taken together these data indicate that 
Pvrl1 is a bona fide p63 transcriptional target gene. 
 
  
Figure 20: Pvrl1 is a direct p63 target gene both in human and in mouse. 
A) ChIP-qPCR of the two identified p63 binding regions (p63BS) in the 
PVRL1 genomic locus was performed in human primary keratinocytes and in 
mouse epidermis. B) p63BS2 enhancer activity was analyzed by luciferase 
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assay in p63 depleted or control keratinocytes (*p-value= 3.12E-06; n=6). Data 
are represented as mean of ± SD of three independent experiments.  
 
4.4 Gene expression analysis of AEC mouse epidermis. 
 
   To obtain a global view of changes in gene expression of AEC mutant mice, 
we performed a comparison of gene expression profiling of mutant versus 
wild-type epidermis at P3 using Affymetrix gene chip. 
  Analysis of the data revealed that a subset of genes, known to be p63 target 
genes, is down-regulated by L514F mutation. Among the p63 targets affected 
in mutant epidermis we found the two fibroblast growth factor receptors Fgfr2 
and Fgfr3 and Krt15 (Ferone et al., 2012), Col17a1 and Dst, two genes 
encoding for hemidesmosome components (Carroll et al., 2006), Ddit4 gene, 
also called Redd1, a developmentally regulated transcriptional target of p63 
and p53, involved in DNA damage (Ellisen et al., 2002), and Notch1 and Jag2, 
two key components of the Notch signaling pathway (Nguyen et al., 2006)(Fig. 
21A).  
   Interestingly, a number of biological processes were de-regulated. In 
particular we observed that epidermal barrier genes involved in arachidonic 
acid and lipid metabolism were strongly downregulated in AEC mutant skin 
(42 genes; p-value= 5.3x10-7), including Alox12, Alox12e and Adh1 (Fig. 
21B).  
   In contrast, AEC mutant epidermis displayed increased focal expression of 
some keratins, including Krt6 and Keratin 16 (Krt16) that were essential to 
maintain keratinocyte integrity in wounded epidermis, and Keratin 8 (Krt8) 
and Keratin 18 (Krt18), simple epithelial keratins, that for their nature could 
participate to intermediate filaments but did not confer strong mechanical 
resistance to the epithelium. Also kallikreins, enzymes with serine protease 
activity that regulate the desquamation of the epidermis (Candi et al., 2005) 
were strongly up-regulated thus indicating an altered equilibrium in epidermis 
structure (Fig. 21C and D).  
   Surprisingly, we found a strong up-regulation of inflammatory genes. In 
particular, we found an up-regulation of one hundred fold of Tslp, an IL-7-like 
cytokine produced by epithelial cells, including keratinocytes that was highly 
expressed in the epidermis of atopic dermatitis and asthmatic patients (Ziegler 
and Artis, 2010) (Fig. 21D). TSLP was produced by epithelial cells and had 
different roles. Indeed, Tslp caused a polarization of dendritic cells to drive T 
helper (Th) 2 cytokine production, promoted T-cell proliferation in response to 
T-cell receptor activation and Th2 cytokine production, and supported B-cell 
expansion and differentiation. TSLP further amplifies Th2 cytokine production 
by mast cells and natural killer T cells.  
In addition to Tslp induction, our microarray data revealed us also the 
induction of damage-associated molecular pattern molecules (DAMPs) that 
initiate the inflammatory response in the event of a disruption of the epidermal 
barrier, such as the inflammatory complex of calprotectin (S100a8/ S100a9 
 	 46	
complex), and -to a lesser extent- antimicrobial peptides, Defb4 and Defb6 
(Fig. 21D). 
 
 Figure 21. Gene expression analysis. A) Microarray data confirmed that a 
subsets of known p63 target genes are affected in the epidermis of L/L mice at 
postnatal day 3 compared to wild-type controls B-D) Microarray data indicated 
that a subset of genes involved in different biological processes were down-
regulated and up-regulated consistently with what we observed in AEC mutant 
mice. 
 
4.5 Inflammation in AEC mouse model  
 
   Skin of mutant mice progressively became hyperplastic with clear signs of 
inflammation at P12. Few days after the first biochemical sign of 
inflammation, epidermis was hyperplastic and hyperkeratotic with neutrophils 
accumulation in the epidermis, a rich cellularization of the dermis accompained 
by a strong induction of Krt6 (Fig. 22 A and B). The presence of infiltrating 
inflammatory cells in the dermis and the upregulation of Krt6 in the epidermis 
of mutant mice suggested that an inflammatory response may be implicated in 
the development of the severe skin phenotype observed at later stages that 
could be related to Tslp induction. 
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   To confirm the microarray data, we verified the expression of Tslp in AEC 
mutant mice respect to controls. QRT-PCR analysis in epidermis of mutant 
mice at P3 confirmed the strong up-regulation of Tslp, which usually is not 
expressed in epidermis. Since Tslp was able to reach the bloodstream to arrive 
in different body districts, we evaluated its expression also in blood serum 
derived from AEC mutant and control mice and we found a high expression of 
Tslp also in blood (Fig. 22C). Interestingly, also in human AEC patients we 
observed an induction of Tslp, thus indicating that Tslp may be involved in 
AEC syndrome and could be the cause of the progressive severe phenotype 
that characterized the AEC mutant mice.  
   Luisa Cirillo, a PhD student in the laboratory is carrying out this part of the 
project. 
 
  
Figure 22: Inflammation in AEC mouse model. A) H&E staining of mutant 
skin sections at P12 revealed a hyperplastic epidermis with clear signs of 
massive inflammation. B) Immunofluorescence analysis of mutant skin 
sections at P7 revealed a strong and abnormal expression of Krt6 in mutant 
epidermis respect to controls. C) (from the left panel) Real-time RT-PCR for 
Tslp in epidermis at P3 confirmed the strong up-regulation of the mRNA levels 
of Tslp (n=7; p-value= 0.01). Data are normalized for β-actin mRNA levels 
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and are represented as mean ± SD normalized mRNA levels; systemic 
accumulation of Tslp protein (ng/ml) in blood serum of mutant mice at P15 
measured by ELISA; Real-time RT-PCR for Tslp in skin derived from AEC 
patients revealed Tslp mRNA up-regulation also in human patients. Data are 
normalized for RPLP0 mRNA levels and are represented as mean ± SD 
normalized mRNA levels. 
 
4.6 Impaired Notch signaling in AEC mutant mice. 
 
   Global gene expression profiling revealed that several biological processes 
are altered in AEC mutant epidermis. Indeed, we confirmed a strong reduction 
of Notch1 and Jag2 expression levels accompanied with reduced expression of 
the Notch1 direct target gene Hes1 in AEC mutant epidermis (Fig. 23A), in 
agreement with previous work indicating that p63 and Notch signaling were 
interconnected and that Notch and Jag2 were direct p63 target genes (Sasaki et 
al., 2002; Laurikkala et al., 2006; Nguyen et al., 2006; Candi et al., 2007). In 
mice loss of Notch signaling led to strong TSLP induction, which was 
suggested to be a consequence of the epidermal barrier failure (Demehri et al., 
2008). Similarly to AEC conditional mouse model, conditional Notch1/Notch2 
mouse model showed severe inflammation, an altered gene expression of genes 
involved in barrier formation and a strong induction of Tslp. Indeed, in Notch-
deficient epidermis Tslp induction was accompanied by defective in skin lipid 
biosynthetic enzymes, with the most strongly inhibited gene being the 
Arachidonate 12-Lipoxigenase (Alox12), and to a lesser extent Alox12e, Adh1, 
and Liph (Demehri et al., 2008)(Fig. 23B and data not shown). 
 
 Figure 23: Notch1 pathway in AEC mouse model. A) Immunoblotting of 
total cell extracts from P3 epidermis of L/L and +/+ mice using antibodies 
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against full-length and NEXT fragment of Notch1. FL: Notch1 Full Length 
protein; NEXT: Notch Extracellular Truncation, cleaved by gamma-secretase. 
Erk was used to normalize samples (on the left). Real-time RT-PCR for Notch1 
(*p-value=0.03; n=7), Jag2 (*p-value=0.02; n=7) and Hes1 (*p-value=0.01; 
n=7) in mouse epidermis derived from L/L and control mice. Data are 
normalized for β-actin mRNA levels and are represented as mean ± SD 
normalized mRNA levels. B) Real-time RT-PCR for Alox12 in mouse 
epidermis derived from L/L and control mice (*p-value=0.002; n=7). Data are 
normalized for β-actin mRNA levels and are represented as mean ± SD 
normalized mRNA levels. 
 
 
4.7 Notch1 is responsible for Alox12 downregulation and Tslp induction in 
AEC mouse model. 
 
Given the strong similarities between AEC mouse model and conditional 
Notch1/Notch2 mouse model, we asked whether restoration of Notch1 
pathway in our system could rescue the expression of genes involved in 
arachidonic acid metabolism, such as Alox12 and could explain the strong 
induction of Tslp. To this aim, I infected keratinocytes derived from AEC 
mutant and control mice both with either retroviruses or adenoviruses carrying 
an active form of Notch1. Following the Notch1 overexpression, I evaluated 
the expression of some known target genes and genes disrupted in AEC mutant 
mice that could be linked to Notch1 signaling. I found that Alox12 was rescued 
by re-activation of Notch pathway, as well as Hes1 (Fig. 24A and B).  
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 Figure 24. Alox12 and Hes1 were rescued by active Notch in AEC mutant 
keratinocytes. A) Real-time RT-PCR for Alox12 and Hes1. mRNA of both 
genes were rescued by retroviral transduction of an active form of Notch1 in 
mutant mouse keratinocytes. Data are normalized for β-actin mRNA levels and 
are represented as mean ± SD normalized mRNA levels. B) Similar results 
were obtained by Adenovirus expressing the transcriptional active form of 
Notch (Ad-NIC). 
 
Interestingly also Tslp expression was influenced by re-activation of Notch1 
pathway since its expression was strongly downregulated by upregulation on 
Notch1 (Fig. 25 A). 
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Figure 25. Tslp expression was regulated by Notch1. Real-time RT-PCR for 
Tslp revealed that both retroviral and adenoviral transduction of an active form 
of Notch1 downregulated the expression of Tslp in vitro (*p<0.001; n=34). 
Data are normalized for β-actin mRNA levels and are expressed relative to 
controls. Error bars denote SD. 
 
   I next inhibited Notch1 activity by using a retrovirus carrying a peptide that 
competes for MAML1 binding to the Notch–CBF-1 complex and prevents 
downstream transcription (Weng et al., 2003). In agreement with previous data, 
suppression of Notch pathway led to an inhibition of Alox12 expression as well 
as of Hes1 whereas, in this condition we were not able to detect a significant 
upregulation of Tslp expression (Fig. 26). 
  
  
Figure 26. Inhibition of Notch1 in cultured keratinocytes led to inhibition 
of Alox12 and Hes1 expression. A) Real-time RT-PCR for Hes1, Alox12 and 
Tslp in cultured keratinocytes derived from mutant and control mice harvested 
under differentiating conditions (2mM Ca++) and infected with a retrovirus 
containing a dominant-negative form of MAML1 reveled that inhibition of 
Notch1 pathway led to a downregulation of Alox12 and Hes1, whereas Tslp 
expression was not affected in these conditions. Data are normalized for β-
actin mRNA levels and are represented as mean ± SD normalized mRNA 
levels. 
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5. DISCUSSION and CONCLUSIONS 
 
   Ankyloblepharon, ectodermal defects, cleft lip/palate (AEC) syndrome is a 
rare autosomal dominant disorder caused by mutations in the p63 gene, 
essential for embryonic development of stratified epithelia. The most severe 
cutaneous manifestation of this disorder is the long-lasting skin fragility 
associated with severe skin erosions after birth. Indeed, in AEC syndrome skin 
is severely affected with approximately 80% of the patients having congenital 
erythroderma and extensive erosions that can lead to the initial misdiagnosis of 
epidermolysis bullosa. Erosions typically involve the scalp, head and neck, 
skin folds, palm and soles, and are often accompanied by crusting, granulation 
tissue and secondary infections and treatments are supportive but not curative 
(Julapalli et al., 2009).  
   Since little is known about the causes of AEC skin erosions, the histological 
and molecular defects, and feasible treatments, we previously generated a 
constitutive mouse model that carries a clinically relevant point mutation in the 
SAM domain of the p63 alpha isoform (L514F) reported in AEC patients. 
   p63+/ L514F mice died at birth with severe cleft palate, skin defects and 
ectodermal dysplasia (Ferone et al., 2012), thus faithfully recapitulating the 
defects observed in AEC syndrome. The cause of death in p63+/ L514F mice was 
cleft palate, which is lethal in mice but not in humans. p63+/ L514F skin 
displayed an overall reduction in skin thickness, accompanied by a significant 
epidermal atrophy and hair follicle hypoplasia. At the molecular level we 
found that the AEC mutation affected proliferation of the epithelial cells of the 
palate and skin, and led to a reduced number of epidermal stem cells. These 
phenotypes were associated with aberrantly low FGF signaling due to reduced 
expression of the FGF receptor Fgfr2, a direct p63 target gene. Importantly, we 
obtained evidences that humans affected by AEC syndrome have similar 
defects of the epidermal stem cell compartment (Ferone et al., 2012). AEC 
mouse skin displayed focal blistering skin lesions, localized mainly between 
the basal and suprabasal layers of the epidermis accompanied with acantholysis 
(loss of intercellular adhesions) and only rarely by cytolysis (rupture of the cell 
membrane). These phenotypes were associated with reduced desmosomal 
contacts in AEC mutant skin. We demonstrated that skin fragility observed in 
the constitutive mouse model was caused by a strong reduction of desmosomes 
and that Dsg1, Dsc3 and Dsp were strongly reduced also in human 
keratinocytes derived from AEC patients and focal downregulation of DSP and 
DSC3 expression was observed in non-lesional skin of AEC patients (Ferone et 
al., 2013; Koster et al., 2014), confirming their possible causative role in the 
pathogenesis of AEC syndrome. 
    
   To overcome the lethality of the constitutive mouse model and to better 
characterize the molecular mechanisms underlined skin erosions and 
hypothetical in vivo treatments, we generated a conditional AEC mouse model. 
The conditional knock-in model (p63+/floxL514F), express the L514F mutation 
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only in the presence of the CRE recombinase. Thus the newly generated 
p63+/floxL514F mouse model expresses only the wild-type p63 and has no 
phenotype until a portion of the inserted DNA is removed by CRE-mediated 
recombination.  We cross p63+/floxL514F with a knock-in mouse expressing Cre 
by E17.5 in epidermis and hair follicle under the control of the endogenous 
keratin 14 (K14) promoter (K14-Cre ∆neo) to obtain both the heterozygous and 
the homozygous model (+/L and L/L) (Huelsken et al., 2001). 
   We begin to characterize the heterozygous model, +/L that show no gross 
abnormalities. We hypothesize that, since the expression of the mutation is late 
in the development a number of biological processes that required p63 
presence are not affected because they happen when the mutation is still off 
and only one copy of mutant p63 is not able to negatively influence these 
processes later. Our observations are quite in contrast with what we observe in 
the constitutive model, in which gene expression analysis lead us to 
hypothesize that L514F mutation acts in a dominant negative fashion. To shed 
light on this discrepancy further analysis on the molecular mechanisms by 
which mutant p63 influences its transcriptional activity will be needed. On the 
other hand it has been reported that sometimes mouse model and human 
disorders are quite different in the genetic contest, therefore our model need to 
be in homozygousity to recapitulate the syndrome. Importantly, alteration of 
the p63 target genes in the conditional homozygous model is comparable to the 
constitutive heterozygous mutant in spite of nearly complete absence of the 
wild-type copy by P0, thus indicating that the L/L model is comparable to the 
constitutive one.  
   L/L mice display a strong phenotype characterized by skin erosions and skin 
crusting. Due to the complex and progressive phenotype a high percentage of 
mutant mice die between 10 and 20 days after birth, whereas those that become 
adults are affected by skin ulcerations, complete hair loss, and severely reduced 
body weight, thus indicating that not only skin but all body districts are 
influenced by p63 mutation.  
   The histological analysis of epidermis reveal altered skin architecture in focal 
points with cells undergoing cytolysis and acantholysis since cells detach both 
from the basal lamina and each other.     
The focal gaps in the epidermal barrier that we observe in mutant mice are 
consistent with focal alteration of the epidermal barrier revealed by X-gal 
penetration assay. The structural integrity of epidermis is ensured by an 
organized cytoarchitecture, thus we hypothesize that the defects that we 
observed in this model are due to alteration in adhesion molecules at different 
levels.  
   It has been postulated that intra-epidermal blistering with areas of both 
acantholysis and cytolysis in perilesional skin of a newborn AEC patient after 
mechanical rubbing are consistent with a disruption in desmosomal 
components (Payne et al., 2005; Ferone et al., 2013). In addition, mutations in 
genes encoding desmosomal components lead to a range of disorders 
characterize by epidermal fragility, blistering, and keratoderma depending on 
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the affected gene (Lai-Cheong et al., 2007). In line with these observations, we 
find a decreased expression of desmosome genes Dsg1, Dsc3 and Dsp and 
reduced mechanical stress resistance, similarly to the constitutive AEC model 
(Ferone et al., 2013).  
   Beside desmosomes, it has been previously suggested that p63 and adherens 
junction component Pvrl1 may be genetically linked because PVRL1 mutations 
in humans cause ectodermal dysplasia and cleft lip/palate (Zlotogora et al., 
1987; Bustos et al., 1991; Suzuki et al., 2000) resembling p63-associated 
syndromes (McGrath et al., 2001). In addition, since PVRL1 and PVRL4 have a 
crucial and partially overlapping role and human mutations in these two genes 
are causative of partially overlapping defects, we hypothesize that also Pvrl4 
may be regulate by p63. Consistent with these hypotheses, we find that Pvrl1 
expression is reduced in keratinocytes derived from AEC patients and from 
conditional AEC mouse models. Surprisingly, Pvrl4 expression is also reduced 
in differentiated AEC keratinocytes, even though its expression is not altered in 
p63 depleted keratinocytes or epidermis. McDade and colleagues demonstrate 
a direct p63 binding on the human PVRL1 promoter in human keratinocytes 
and its responsiveness to p63 in heterologous cells (McDade et al., 2012). We 
demonstrate that Pvrl1 expression is impaired in p63-depleted keratinocytes 
and in p63 null embryonic skin and that two conserved intronic regions are 
strongly bound by p63 in mouse keratinocytes, again indicating that Pvrl1 is a 
p63 direct target gene (Mollo et al., 2014). 
   A transcriptomic profile of AEC patients skin has been published and 
postulated that skin erosions in AEC patients could be due to defects in FRAS1 
and COL7A1 expression (Clements et al., 2012). The extracellular matrix 
protein Col7a1 is a major component of the anchoring fibrils at the dermal–
epidermal junctions (Burgeson, 1993). Mutations in COL7A1 result in 
dystrophic epidermolysis bullosa (DEB); a major type of EB caused by 
disrupted dermal/epidermal adhesion (Dang and Murrell, 2008). We find that 
in our mouse model Col7A1 but not Fras1 expression is disrupted, thus 
supporting the idea that epidermal blistering in AEC mouse model may be due 
also to alteration in different structures that regulate adhesion processes.  
Accordingly, several studies indicate that p63 is a crucial transcriptional 
regulator of genes involved in cell-matrix adhesion and cell-cell adhesion 
genes, directly regulating a subset of extracellular matrix, hemidesmosomal, 
desmosomal, adherens junction and tight junction components (reviewed in 
(Ferone et al., 2015)). 
   Given that alteration in desmosomes and adherens junctions are evident only 
in mutant keratinocytes but not in epidermis, an hypothesis is that 
compensatory mechanisms may act in vivo thus protect the weakness of these 
structures, but given the strong phenotype, other molecules have to be involved 
in the skin fragility and erosions in mutant mice. 
   The structural integrity of epidermal keratinocytes is maintained also by a 
filamentous network made up of keratins (Magin et al., 2000). Since it has 
been suggested that the overall function of epidermal keratin filaments is to 
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impart mechanical integrity to the cells, without which, the cells become 
fragile and prone to rupturing, we hypothesize that alteration in intermediate 
filaments in the basal layer of the epidermis may explain epidermal blisters in 
AEC syndrome.  
   Keratins belong to the superfamily of intermediate filament (IF) proteins, 
which have the capacity to assemble to form obligatory heteropolymers, indeed 
they are often coexpressed as specific pairs in vivo (Hutton et al., 1998). In 
particular, the basal layer of the epidermis is characterized by heteropolymers 
of Krt5 and Krt14. It is now well established that mechanically induced 
blistering disorders of the epidermis involve mutations in keratins and often the 
severity of these diseases seems to correlate with the degree to which the 
keratin mutants perturb IF assembly in vitro (Bonifas et al., 1991; Coulombe et 
al., 1991). In addition, since p63 induces expression of keratins typical of 
stratified epithelia and suppresses simple epithelium keratins (De Rosa et al., 
2009), we hypothesize that in mutant keratinocytes the balance between these 
keratins could be affected thereby reducing epidermal resilience. 
   Interestingly, we find that in AEC mutant epidermis Krt5 is strongly 
downregulated, in spite of a normal amount of Krt14. Ultrastructural analysis 
demonstrate reduce keratin bundles in the basal layer of the epidermis, thus 
indicating that the reduction of Krt5 is able to perturb the assembly of keratin 
bundles in mutant epidermis. In contrast, we observe that both Krt5 and Krt14 
expression is strongly downregulated in p63 knockdown and in AEC mutant 
keratinocytes indicating that in vivo p63 plays a crucial function in Krt5 
regulation whereas Krt14 expression maybe sustain by other transcription 
factors, such as AP1 and AP2 (Sinha et al., 2000; Romano et al., 2007). 
   The severity of skin erosion in AEC patients often leads to misdiagnosis, 
confusing AEC syndrome with epidermolysis bullosa simplex, a genetic 
disorder caused by mutations in intermediate filaments as Krt5 (Muller et al., 
2006). Importantly reduced KRT5 is observed also in human samples derived 
from AEC patients both at the RNA and protein levels, thus reinforcing the 
idea that in AEC syndrome impaired intermediate filaments network may be 
responsible for skin fragility and epidermal blistering.  
 
   Global gene expression profile of AEC mutant epidermis reveals that a 
number of epidermal genes are affected. Indeed, p63 is a master regulator of 
gene expression in the epidermis and in other stratified epithelia and positively 
controls a large number of tissue-specific genes. As the main regulator of skin, 
p63 mutation affects different processes related to skin development and 
manteinance. Indeed , as indicators of altered epidermal structure, we find that 
by P3, Krt6 and Krt16 are strongly upregulated. Krt6 and Krt16 are being 
regarded as the most sensitive indicators of disturbances in epidermal 
homeostasis (McGowan and Coulombe, 1998). In control animals  they are 
restricted to hair follicles and foot sole epidermis and are absent in 
interfollicular epidermis but after mechanical stress or tissue injury or as a 
result of hyperproliferation they are strongly induced in interfollicular 
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epidermis (Peters et al., 2001). In addition, we find an upregulation of Klk5, 
Klk6, Klk7 and Klk10, serin-protease named kallikreins that coordinate the 
desquamation mechanism, a process that lead to the shedding of the outer 
epidermis. The correct balance between these protease and their inhibitors 
preserve epidermal homeostasis and provide an environmental barrier (Candi et 
al., 2005). Concomitant with Krt6 and Krt16 induction, we observe significant 
induction of damage-associated molecular pattern molecules (DAMPs) that 
initiate the inflammatory response in the event of a disruption of the epidermal 
barrier, such as the inflammatory complex calprotectin (S100a8/ S100a9 
complex), and -to a lesser extent- antimicrobial peptides, Defb4 and Defb6. 
Taken together these data lead us to hypothesize that the epidermal barrier 
formation and the differentiation program of mutant epidermis does not occur 
properly and may be at the basis of the inflammatory phenotype that we 
observe at later stages. 
 
   Skin of mutant mice is characterized by a strong induction of Tslp, an IL-7-
like cytokine produced by epidermal cells. Interestingly, Tslp is impicated in 
different disorders beyond allergic inflammation including atopic dermatitis 
(AD), a chronic inflammatory skin disease in which Tslp protein is highly 
expressed in acute and chronic lesions (Ziegler and Artis, 2010). In mice, 
overexpression of Tslp specifically in the skin was sufficient to induce a 
disease phenotype characterized by all the hallmark features of AD (Yoo et al., 
2005). In addition, several models of induced Tslp expression in skin result in 
subsequent allergic airway inflammation, suggesting that Tslp may reach and 
act in different body districts leading to different systemic disorders (Demehri 
et al., 2009; Fontenot et al., 2009; Leyva-Castillo et al., 2013). Tslp is also 
overexpressed in the skin of individuals with Netherton syndrome (NS), a 
severe skin disease characterized by AD-like lesions as well as other allergic 
manifestations that result from mutations in the serine peptidase inhibitor 
Kazal-type 5 (SPINK5) gene. These observations lead us to hypothesize a 
fundamental role of Tslp in our mouse model in the development and 
progression of inflammatory phenotype throughout the body. Indeed, few days 
after the expression of Tslp, surviving L/L mice are characterized by a 
chronically thickened epidermis, dry skin, severe inflammatory dermal 
infiltrates, and a systemic myeloproliferative disease that may be the cause of 
the high mortality rate of mutant mice. Interestingly, an autoimmune disorder 
is observed in at least one AEC patient with severe skin erosions, indicating 
that the release of TSLP may be at basis of a systemic autoimmune condition 
also in individuals affected by AEC syndrome. This patient had severe skin 
erosions occurring soon after birth in 70% of the body. Unfortunately, AEC 
syndrome was associated later in life (age 6) with the systemic disorder that 
was later diagnosed as an autoimmune proliferative disorder (age 8) 
(http://nfed.org/index.php/meet_our_families/single/the-miracle-child), 
suggesting that skin inflammation may have systemic consequences, possibly 
due to excess TSLP release in the blood stream. The disease was not 
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investigated in depth at the time, and the child was placed under prednisone, 
and at the age of 16 is still on a very low dose of mycophenolate mofetil (Mark 
Atlas, MD Pediatric Hematology-Oncology doctor; personal communication). 
We tested his levels of TSLP in the blood, but found no difference with 
matching controls, consistent with the remission of the disease. In spite of this 
data, we evaluate TSLP mRNA levels in epidermis of human AEC patients and 
we observe an induction of Tslp, thus indicating that Tslp may be involved in 
AEC syndrome and could be the cause of the progressive severe phenotype 
that characterized the AEC mutant mice. In addition, gene expression profile in 
human AEC samples reveals that in eroded scalp skin there is a significant 
upregulation of several S100 genes as S100A8 and S100A9 that are proteins 
associated with acute and chronic skin inflammation (Clements et al., 2012). 
Interestingly, in AEC mouse model we find the same upregulation that, 
together with the induction of Tslp indicate that acute and chronic 
inflammation may play a key role in the progression of the disease both in 
human and mouse.  
 
   In a search for other mouse models in which Tslp may be similarly massively 
upregulated, we find that comparable Tslp production is observed in mice with 
a Notch-deficient skin (Demehri et al., 2008; Dumortier et al., 2010; Murthy et 
al., 2012). Indeed, ablation of cutaneous Notch signaling in mice results in the 
overexpression of Tslp causing a chronic inflammatory disorder resembling 
atopic dermatitis (Demehri et al., 2008; Dumortier et al., 2010). In spite of the 
fact that inflammation appears to be extremely sensitive to aberrations in 
epidermal Notch signaling, the mechanism by which Notch signaling is able to 
regulate inflammation and in particular Tslp remains unclear. Of note, TSLP 
has been proposed to be produced as a consequence of skin barrier defects in 
general and does not depend on loss of Notch signaling directly (Demehri et 
al., 2008) whereas others postulated a direct regulation of Notch1 on Tslp 
promoter (Murthy et al., 2012).  
These data lead us to hypothesize that the induction of Tslp in AEC mouse 
model may be due to impair Notch signaling.  
   Notch signaling is necessary for proper epidermal differentiation and lipid 
deposition. Altered epidermal differentiation and lipid deposition lead to 
release of high levels of TSLP into the systemic circulation. Therefore TSLP is 
a keratinocyte ‘‘quality control’’ response to defective 
differentiation/epidermal barrier (Demehri et al., 2008).  
   Importantly, in AEC mutant epidermis we observe a strong reduction of 
Notch1 and Jag2 expression levels accompanied with reduced expression of 
the Notch1 direct target gene Hes1. In addition a strong reduction of lipid 
biosynthetic enzymes was observed in AEC mutant skin at P3, with reduced 
expression of genes involved in arachidonic acid metabolism and lipid 
metabolism (42 genes; p-value= 5.3x10-7), including Alox12, Alox12e, Adh1.          
   Interestingly, it has been reported that the dry skin phenotype of intact AEC 
syndrome skin and the eroded skin sample are also associated with changes in 
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several structural proteins implicated in lipid metabolism that may have a role 
in barrier formation. Consistently, the expression of genes involved in 
arachidonic acid metabolism, such as ALOX15B and ALOX5AP, is affected 
also in skin of human individuals affected by AEC syndrome (Clements et al., 
2012).   
   To better understand the role of Notch1 deficiency in AEC mouse model in 
regulating the expression of both Tslp and Alox12 we exogenously expressed 
Notch1 in mutant keratinocytes.      
Surprisingly, although Alox12 is also directly controlled by p63 (Kim et al., 
2009), expression in mouse primary keratinocytes isolated from AEC mutant 
mice is rescued by overexpression of exogenous active Notch1, whereas 
infection with a retrovirus carrying a peptide that competes for MAML1 
binding to the Notch–CBF-1 complex and prevents downstream transcription 
(Weng et al., 2003), inhibits Hes1 and Alox12 in wild-type keratinocytes.  
These data indicate that the severity of skin phenotypes of AEC patients is 
linked to different altered pathway, among which arachidonic acid metabolism 
may be play an unexplored role. 
   Interestingly also Tslp expression is influenced by re-activation of Notch1 
pathway since its expression is strongly downregulated by upregulation of 
Notch1. These results support the idea that Notch1 may directly regulate Tslp 
expression; therefore we need to further investigate this point.     
    
   In conclusion, we demonstrate that the basal cell fragility and blistering 
observed in AEC mutant mice are due to alteration in adhesion molecules 
belonged to different categories. Interestingly, we establish a key role of 
intermediate filaments in the basal layer of the epidermis of AEC mouse 
model, which integrity is fundamental to give mechanical resilience to the 
epidermis. For the first time we evaluate the contribution of Krt5 in the 
progression of skin erosions in AEC syndrome therefore paving the way for 
new feasible treatments aimed at restoration of keratins functionality.  
Importantly, we explore the possibility that altered skin barrier due to 
unbalanced keratin bundles in the basal layer and alteration of lipid and 
arachidonic acid metabolism, leads to inflammation, driven by upregulation of 
Tslp. An active role in this process may be play by Notch signaling which 
deficiency is responsible for the aberrant expression of Tslp.  
Of note, these observations are true also in human AEC patients, thus 
reinforcing the idea that L/L mouse model may be a useful model to study the 
AEC syndrome.  
   Taken together, these data shed light on the clarification of the molecular 
mechanisms underling skin defects observed in AEC patients. 
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Figure 27. Proposed model. Mutant p63 affects both intermediate filaments 
network, through a strong reduction of Krt5 expression and inhibit Notch1 
signaling. Krt5 reduction may be account for the skin fragility observed in 
AEC mouse model and, together with impaired Notch1 signaling lead to an 
epidermal barrier dysfunction. The absence of a negative control of Notch1 and 
the epidermal barrier failure lead to an upregulation of Tslp that may be 
explain the chronic inflammation that is observed in AEC mouse model. 
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